Fluid discharge device, system and method
The glaucoma shunt with a microporous material transitioning from hydrophobic to hydrophilic state addresses the issues of conventional shunts by minimizing tissue irritation and scarring, effectively managing intraocular pressure.
Patent Information
- Application Number
- KR1020247018823
- Authority / Receiving Office
- KR · KR
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2022-11-03
- Filing Date
- 2022-11-04
- Publication Date
- 2026-11-10
- Estimated Expiration
- 2042-11-04
Smart Images

Figure R1020247018823_ABST
Abstract
Description
Technology Field
[0001] Cross-reference regarding related applications
[0002] This application claims priority to U.S. Provisional Application No. 63 / 276,170 filed November 5, 2021 and U.S. Application No. 17 / 980,417 filed November 3, 2022, each of which is incorporated herein by reference in its entirety.
[0003] The present disclosure generally relates to an apparatus, system, and method for diverting the flow of fluid so that it is discharged and reabsorbed elsewhere in the body. More specifically, the present disclosure relates to an apparatus, system, and method for discharging aqueous humor from the anterior chamber of a patient's eye so that it can be reabsorbed by the body. Background Technology
[0004] Various medical interventions involve removing excess fluid, such as biological fluid, from one part of the body and redirecting it to another location where it can be reabsorbed. In certain examples, the removal of such excess fluid is achieved through minimally invasive procedures, such as endoscopic third ventricle opening (ETV) and choroidal retinal cauterization (CPC). In other examples, the removal of such excess fluid is performed postoperatively using implantable medical devices, such as shunts. Different types of shunts, proven useful in various medical procedures, have been used in the treatment of numerous diseases, such as hydrocephalus and glaucoma.
[0005] If left untreated, excess biological fluid can lead to an unhealthy increase in pressure. For example, glaucoma is a progressive eye disease characterized by elevated intraocular pressure. Aqueous humor is the fluid that fills the anterior chamber of the eye and contributes to intraocular pressure or intraocular fluid pressure. This increase in intraocular pressure is generally caused by an insufficient amount of aqueous humor absorbed by the body. In some cases, the aqueous humor is not absorbed quickly enough or at all, while in others, it is produced additionally or, alternatively, too quickly. Elevated intraocular pressure is associated with progressive, and sometimes permanent, loss of vision in the affected eye.
[0006] There have been many attempts to treat glaucoma. However, some conventional devices are relatively bulky and lack the device / tissue adhesion, compliance, and flexibility necessary to avoid relative movement between the device and surrounding tissues. Such movement can lead to continuous irritation of surrounding tissues, causing irritation at the implant site. Consequently, irritation can lead to chronic inflammatory tissue responses, excessive scarring at the device site, and an increased risk of device erosion through conjunctivitis and endophthalmitis. Scar tissue substantially blocks the reabsorption of aqueous humor without erosion. The aforementioned complications can prevent the device from functioning properly. The result is a gradual increase in intraocular pressure and the progression of glaucoma. Prior art literature
[65535] U.S. Patent Publication US 9,375,347 B2 (June 28, 2016) means of solving the problem
[0007] According to one embodiment (“Example 1”), a glaucoma shunt for draining fluid from the eye to the tissues surrounding the eye is disclosed herein. The glaucoma shunt is implantable within the tissues of the eye and comprises: a shunt body formed of a microporous material disposed to form a reservoir within the shunt body; and a conduit that is fluidly communicating with the reservoir and is implantable in the eye so as to allow fluid at the distal end of the conduit to flow through the conduit and accumulate in the reservoir. As the fluid accumulated in the reservoir is dispersed through the microporous material to the tissues surrounding the eye, the microporous material transitions from a hydrophobic state to a hydrophilic state within 30 days, thereby providing variable flow resistance as the microporous material transitions from a hydrophobic state to a hydrophilic state.
[0008] According to another embodiment ("Example 2") regarding Example 1, a first portion of the microporous material transitions from a hydrophobic state to a hydrophilic state within 3 days.
[0009] According to another embodiment of Example 2 ("Example 3"), a second part of the microporous material, different from the first part, transitions from a hydrophobic state to a hydrophilic state within 7 days.
[0010] According to another example ("Example 4") regarding any prior example, the entire microporous material transitions from a hydrophobic state to a hydrophilic state within 30 days.
[0011] According to another example ("Example 5") regarding any prior example, in a hydrophobic state, the microporous material is opaque.
[0012] According to another example ("Example 6") regarding any prior example, in a hydrophilic state, the microporous material is transparent.
[0013] According to another embodiment ("Example 7") regarding any prior example, the shunt body has a maximum thickness of 500 μm or less.
[0014] According to another embodiment ("Example 8") regarding any prior example, in a hydrophobic state, a water droplet placed on the surface of a microporous material forms a contact angle greater than 90 degrees with respect to the surface, and in a hydrophilic state, a water droplet placed on the surface of a microporous material forms a contact angle less than 90 degrees with respect to the surface. The transition from a hydrophobic state to a hydrophilic state results in a reduction of the contact angle by at least 10 degrees.
[0015] According to another embodiment ("Example 9") regarding any prior example, the variable flow resistance is greater in the hydrophobic state than in the hydrophilic state.
[0016] According to another example ("Example 10") regarding any prior example, the microporous material is more translucent in the hydrophilic state than in the hydrophobic state.
[0017] According to another embodiment ("Example 11") relating to any prior example, the shunt body comprises a continuous wall forming a reservoir, wherein a reservoir opening in the continuous wall communicates with an internal reservoir and the conduit is received interlockingly through the opening. At least a portion of the continuous wall has a wall portion composed of a microporous material. The wall portion has an inner surface facing the internal reservoir and an outer surface on the opposite side facing the external area of a human eye. The inner surface of the wall portion has a low-porous surface extending across the entire inner surface of the wall portion. The outer surface of the wall portion has an alternating surface comprising a low-porous surface positioned between high-porous surfaces.
[0018] According to another embodiment ("Example 12") regarding any prior example, the microporous material comprises a first layer having a first microporous membrane integrated with a second microporous membrane and a second layer having a third microporous membrane integrated with a fourth microporous membrane.
[0019] According to another example ("Example 13") regarding Example 12, the microporous material comprises expanded polytetrafluoroethylene (ePTFE).
[0020] According to another embodiment of Example 13 ("Example 14"), the first microporous membrane permeability of the first microporous membrane is greater than the second microporous membrane permeability of the second microporous membrane. The fourth microporous membrane permeability of the fourth microporous membrane is greater than the third microporous membrane permeability of the third microporous membrane.
[0021] According to another embodiment of Example 14 ("Example 15"), the first layer and the second layer are laminated such that the first microporous membrane and the fourth microporous membrane are the outermost membranes of the shunt body, and the second microporous membrane and the third microporous membrane are the innermost membranes of the shunt body forming a reservoir.
[0022] According to another embodiment of Example 12 ("Example 16"), the first microporous membrane has first microporous membrane permeability, the second microporous membrane has second microporous membrane permeability, the third microporous membrane has third microporous membrane permeability, and the fourth microporous membrane has fourth microporous membrane permeability. The second microporous membrane permeability is approximately the same as the third microporous membrane permeability, and the first microporous membrane permeability is approximately the same as the fourth microporous membrane permeability. The second microporous membrane permeability and the third microporous membrane permeability are each different from the first microporous membrane permeability and the fourth microporous membrane permeability.
[0023] According to another embodiment of Example 12 ("Example 17"), the second and third microporous membranes are bonded together along the peripheral edges of the first and second layers to form a reservoir and place the reservoir between the second and third microporous membranes. The second and third microporous membranes are configured to resist tissue endogrowth. The second and third microporous membranes have an extended state maintained adjacent to the peripheral edges of the first and second layers.
[0024] According to another embodiment of Example 12 ("Example 18"), the reservoir is configured to move between a contracted state in which the second and third microporous membranes resist fluid flow between them, and an expanded state in which fluid is allowed to flow between the second and third microporous membranes.
[0025] According to another embodiment of Example 18 ("Example 19"), fluid flow into the reservoir is directed from the distal end of the conduit toward the periphery of the chamber.
[0026] According to another embodiment of Example 18 ("Example 20"), the reservoir has a reservoir proximal section adjacent to the distal end of the conduit and a reservoir distal section positioned opposite the reservoir proximal section. During fluid discharge, the reservoir proximal section is configured to expand ahead of the reservoir distal section.
[0027] According to another embodiment ("Example 21") regarding any prior example, the variable flow resistance corresponds to the rate of change of pressure with respect to the flow rate over time.
[0028] According to another embodiment of Example 21 ("Example 22"), the microporous material transitions from a hydrophobic state with a first flow resistance to a partially hydrophilic state with a second flow resistance, and subsequently to a hydrophilic state with a third flow resistance. The first flow resistance is greater than both the second flow resistance and the third flow resistance, and the second flow resistance is greater than the third flow resistance.
[0029] According to another embodiment ("Example 23") regarding any prior example, the microporous material is configured to transition from a hydrophobic state to a hydrophilic state based on wetting of the microporous material by a fluid. The microporous material is configured such that wetting of the outer portion of the shunt body occurs prior to wetting of the reservoir.
[0030] According to another embodiment ("Example 24"), an aqueous dispersion device is disclosed herein. The device comprises a device body formed of a microporous material disposed to form a reservoir within the device body, the reservoir being configured to receive and accumulate fluid. As the fluid accumulated in the reservoir is dispersed through the microporous material into a tissue surrounding the device, the microporous material transitions from a hydrophobic state to a hydrophilic state within 30 days, thereby providing variable flow resistance as the microporous material transitions from a hydrophobic state to a hydrophilic state.
[0031] According to another embodiment of Example 24 ("Example 25"), a first portion of the microporous material transitions from a hydrophobic state to a hydrophilic state within 3 days.
[0032] According to another embodiment of Example 25 ("Example 26"), a second part of the microporous material, different from the first part, transitions from a hydrophobic state to a hydrophilic state within 7 days.
[0033] According to another example ("Example 27") regarding any one of Examples 24-26, the entire microporous material transitions from a hydrophobic state to a hydrophilic state within 30 days.
[0034] According to another example ("Example 28") regarding any one of Examples 24-27, in a hydrophobic state, the microporous material is opaque.
[0035] According to another example ("Example 29") regarding any one of Examples 24-28, in the hydrophilic state, the microporous material is transparent.
[0036] According to another embodiment ("Example 30") relating to any one of Examples 24-29, the shunt body has a maximum thickness of 500 μm or less.
[0037] According to another embodiment ("Example 31") relating to any one of Examples 24-30, in the hydrophobic state, a water droplet placed on the surface of the microporous material forms a contact angle greater than 90 degrees with respect to the surface, and in the hydrophilic state, a water droplet placed on the surface of the microporous material forms a contact angle less than 90 degrees with respect to the surface. The transition from the hydrophobic state to the hydrophilic state results in a reduction of the contact angle by at least 10 degrees.
[0038] According to another embodiment ("Example 32") regarding any one of Examples 24-31, the variable flow resistance is greater in the hydrophobic state than in the hydrophilic state.
[0039] According to another example ("Example 33") regarding any one of Examples 24-32, the microporous material is more translucent in the hydrophilic state than in the hydrophobic state.
[0040] According to another embodiment ("Example 34") relating to any one of Examples 24-33, the microporous material comprises a first layer having a first microporous membrane bonded to a second microporous membrane and a second layer having a third microporous membrane bonded to a fourth microporous membrane.
[0041] According to another example ("Example 35") regarding Example 34, the microporous material comprises expanded polytetrafluoroethylene (ePTFE).
[0042] According to another embodiment of Example 35 ("Example 36"), the first microporous membrane permeability of the first microporous membrane is greater than the second microporous membrane permeability of the second microporous membrane. The fourth microporous membrane permeability of the fourth microporous membrane is greater than the third microporous membrane permeability of the third microporous membrane.
[0043] According to another embodiment of Example 36 ("Example 37"), the first layer and the second layer are stacked such that the first microporous membrane and the fourth microporous membrane are the outermost membranes of the device body, and the second microporous membrane and the third microporous membrane are the innermost membranes of the device body forming a reservoir.
[0044] According to another embodiment of Example 34 ("Example 38"), the first microporous membrane has first microporous membrane permeability, the second microporous membrane has second microporous membrane permeability, the third microporous membrane has third microporous membrane permeability, and the fourth microporous membrane has fourth microporous membrane permeability. The second microporous membrane permeability is approximately the same as the third microporous membrane permeability, and the first microporous membrane permeability is approximately the same as the fourth microporous membrane permeability. The second microporous membrane permeability and the third microporous membrane permeability are each different from the first microporous membrane permeability and the fourth microporous membrane permeability.
[0045] According to another embodiment of Example 34 ("Example 39"), the second and third microporous membranes are bonded together along the peripheral edges of the first and second layers to form a reservoir and place the reservoir between the second and third microporous membranes. The second and third microporous membranes are configured to resist tissue endogrowth. The first and fourth microporous membranes are configured to allow tissue endogrowth. The second and third microporous membranes have an extended state maintained adjacent to the peripheral edges of the first and second layers.
[0046] According to another embodiment of Example 34 ("Example 40"), the reservoir is configured to move between a contracted state in which the second and third microporous membranes resist fluid flow between them, and an expanded state in which fluid is allowed to flow between the second and third microporous membranes.
[0047] According to another embodiment of Example 40 ("Example 41"), fluid flow into the reservoir is directed from the proximal part of the reservoir toward the periphery of the chamber.
[0048] According to another embodiment of Example 40 ("Example 42"), the reservoir has a reservoir proximal section configured to be positioned adjacent to a reservoir port through which the fluid to be received passes, and a reservoir distal section configured opposite to the reservoir proximal section. During the discharge of the fluid, the reservoir proximal section is configured to expand ahead of the reservoir distal section.
[0049] According to another embodiment ("Example 43") regarding any one of Examples 24-42, the variable flow resistance corresponds to the rate of change of pressure with respect to the flow rate over time.
[0050] According to another embodiment of Example 43 ("Example 44"), the microporous material transitions from a hydrophobic state with a first flow resistance to a partially hydrophilic state with a second flow resistance, and subsequently to a hydrophilic state with a third flow resistance. The first flow resistance is greater than both the second flow resistance and the third flow resistance, and the second flow resistance is greater than the third flow resistance.
[0051] According to another embodiment ("Example 45") relating to any one of Examples 24-44, the microporous material is configured to transition from a hydrophobic state to a hydrophilic state based on wetting of the microporous material by a fluid. The microporous material is configured such that wetting of the outer part of the device body occurs prior to wetting of the reservoir.
[0052] According to another embodiment ("Example 46"), a method for forming an implantable glaucoma drainage device is disclosed. The method comprises: a step of arranging a microporous material to form a device body formed therein, wherein the reservoir is configured to receive and accumulate fluid; and a step of fixing a portion of the microporous material forming the reservoir so as the microporous material transitions from a hydrophobic state to a hydrophilic state within 30 days as the fluid accumulates in the reservoir, thereby providing variable flow resistance as the microporous material transitions from a hydrophobic state to a hydrophilic state as the fluid is dispersed through the microporous material into tissues surrounding the device.
[0053] According to another embodiment of Example 46 ("Example 47"), a first portion of the microporous material transitions from a hydrophobic state to a hydrophilic state within 3 days.
[0054] According to another embodiment of Example 47 ("Example 48"), a second part of the microporous material, different from the first part, transitions from a hydrophobic state to a hydrophilic state within 7 days.
[0055] According to another example ("Example 49") regarding any one of Examples 46-48, the entire microporous material transitions from a hydrophobic state to a hydrophilic state within 30 days.
[0056] According to another example ("Example 50") regarding any one of Examples 46-49, in a hydrophobic state, the microporous material is opaque.
[0057] According to another example ("Example 51") relating to any one of Examples 46-50, in a hydrophilic state, the microporous material is transparent.
[0058] According to another embodiment ("Example 52") relating to any one of Examples 46-51, the shunt body has a maximum thickness of 500 μm or less.
[0059] According to another embodiment ("Example 53") relating to any one of Examples 46-52, in the hydrophobic state, a water droplet placed on the surface of the microporous material forms a contact angle greater than 90 degrees with respect to the surface, and in the hydrophilic state, a water droplet placed on the surface of the microporous material forms a contact angle less than 90 degrees with respect to the surface. The transition from the hydrophobic state to the hydrophilic state results in a reduction of the contact angle by at least 10 degrees.
[0060] According to another embodiment ("Example 54") regarding any one of Examples 46-53, the variable flow resistance is greater in the hydrophobic state than in the hydrophilic state.
[0061] According to another example ("Example 55") regarding any one of Examples 46-54, the microporous material is more translucent in the hydrophilic state than in the hydrophobic state.
[0062] According to another embodiment ("Example 56") relating to any one of Examples 46-55, the reservoir receives fluid through a port of the device body. The method further includes the step of securing a suction conduit configured to receive drainage from the port to the device body.
[0063] According to another embodiment ("Example 57") relating to any one of Examples 46-56, one or more microporous materials comprise a first layer having a first microporous membrane bonded to a second microporous membrane and a second layer having a third microporous membrane bonded to a fourth microporous membrane. Fixing a portion of one or more microporous materials comprises bonding the second microporous membrane to the third microporous membrane.
[0064] According to another embodiment of Example 57 ("Example 58"), the second and third microporous membranes are bonded together along the peripheral edges of the first and second layers to form a reservoir and place the reservoir between the second and third microporous membranes. The second and third microporous membranes are configured to resist tissue endogrowth. The first and fourth microporous membranes are configured to allow tissue endogrowth. The second and third microporous membranes have an extended state maintained adjacent to the peripheral edges of the first and second layers.
[0065] According to another embodiment of Example 57 ("Example 59"), fixing a portion of the microporous material includes preventing the first microporous membrane from being bonded to the fourth microporous membrane.
[0066] According to another embodiment of Example 57 ("Example 60"), fixing a portion of the microporous material comprises arranging the first layer and the second layer in a stacked configuration such that the first microporous membrane and the fourth microporous membrane are the outermost membranes of the device body and the second microporous membrane and the third microporous membrane are the innermost membranes of the device body.
[0067] According to another embodiment (“Example 61”), a glaucoma drainage device for draining fluid from an internal region of a human eye to an external region of a human eye is disclosed herein. The device comprises a body having a continuous wall forming an internal reservoir within the body and a reservoir opening in the wall communicating with the internal reservoir, and a conduit extending from the body by a conduit length. The conduit has a first end and a second end opposite each other and forms a passage through the conduit extending between the first end and the second end opposite each other, the first end of the conduit engages with the reservoir opening to provide a fluid connection between the second end of the conduit and the reservoir, and the conduit length is sufficient to position the first end of the conduit in the external region of the human eye and the second end of the conduit in the internal region of the human eye. At least a portion of the continuous wall has a wall portion composed of a microporous material. The wall portion has an inner surface facing the storage area and an outer surface on the opposite side facing the external area of the human eye, and the low-porous surface of the inner surface of the wall portion extends over the entire inner surface of the wall portion. The outer surface of the wall portion has an alternating surface comprising a low-porous surface disposed between high-porous surfaces. The wall portion has an initial hydrophobic state, and when a fluid comes into contact with the wall portion, the initial hydrophobic state transitions to a final hydrophilic state within 30 days.
[0068] According to another embodiment of Example 61 ("Example 62"), a first portion of the microporous material transitions from a hydrophobic state to a hydrophilic state within 3 days.
[0069] According to another embodiment of Example 62 ("Example 63"), a second part of the microporous material, different from the first part, transitions from a hydrophobic state to a hydrophilic state within 7 days.
[0070] According to another example ("Example 64") regarding any one of Examples 61-63, the entire microporous material transitions from a hydrophobic state to a hydrophilic state within 30 days.
[0071] According to another example ("Example 65") regarding any one of Examples 61-64, in a hydrophobic state, the microporous material is opaque.
[0072] According to another example ("Example 66") regarding any one of Examples 61-65, in a hydrophilic state, the microporous material is transparent.
[0073] According to another embodiment ("Example 67") relating to any one of Examples 61-66, the shunt body has a maximum thickness of 500 μm or less.
[0074] According to another embodiment ("Example 68") relating to any one of Examples 61-67, in the hydrophobic state, a water droplet placed on the surface of the microporous material forms a contact angle greater than 90 degrees with respect to the surface, and in the hydrophilic state, a water droplet placed on the surface of the microporous material forms a contact angle less than 90 degrees with respect to the surface. The transition from the hydrophobic state to the hydrophilic state results in a reduction of the contact angle by at least 10 degrees.
[0075] According to another embodiment ("Example 69") regarding any one of Examples 61-68, the variable flow resistance is greater in the hydrophobic state than in the hydrophilic state.
[0076] According to another example ("Example 70") regarding any one of Examples 61-69, the microporous material is more translucent in the hydrophilic state than in the hydrophobic state.
[0077] According to another embodiment ("Example 71") relating to any one of Examples 61-70, the wall portion forms a wall portion thickness extending between the inner surface and the outer surface. The wall portion thickness forms an internal region of the wall portion having transitional porosity between the porosity of the low-porous surface of the inner surface and the porosity of the high-porous surface of the outer surface.
[0078] According to another embodiment ("Example 72") relating to any one of Examples 61-70, the wall portion forms a wall portion thickness extending between the inner surface and the outer surface. The wall portion thickness forms an internal region of the wall portion extending between the low-porous surface of the inner surface and the low-porous surface of the outer surface. The internal region has the same internal region porosity as the porosity of the low-porous surfaces of the inner and outer surfaces.
[0079] According to another embodiment ("Example 73") relating to any one of Examples 61-70, the wall portion forms a wall portion thickness extending between the inner surface and the outer surface. The wall portion thickness forms an internal region of the wall portion extending between the low-porous surface of the inner surface and the high-porous surface of the outer surface. The internal region has the same internal region porosity as the porosity of the low-porous surface of the inner surface.
[0080] According to another embodiment ("Example 74") relating to any one of Examples 61-70, the wall portion forms a wall portion thickness extending between the inner surface and the outer surface. The wall portion thickness forms an internal region of the wall portion extending between the low-porous surface of the inner surface and the high-porous surface of the outer surface. The internal region has the same internal region porosity as the porosity of the high-porous surface of the outer surface.
[0081] According to another embodiment ("Example 75") relating to any one of Examples 61-74, the fluid connection between the second end of the conduit and the reservoir is further extended from the reservoir through a microporous material to provide fluid communication from the reservoir to an area outside the human eye.
[0082] According to another embodiment of Example 75 ("Example 76"), the fluid communication forms a flow path through a microporous material.
[0083] According to another embodiment of Example 76 ("Example 77"), the flow path through the microporous material is in a direction away from the reservoir.
[0084] According to another embodiment of Example 76 ("Example 78"), the flow path through the microporous material proceeds from a microporous region with low porosity to a microporous region with high porosity.
[0085] According to another embodiment (“Example 79”), a method for controlling the flow of fluid from the eye to the tissues surrounding the eye is disclosed. The method comprises: a step of expanding the reservoir with fluid positioned to come into contact with a hydrophobic material that forms a reservoir and provides a first flow resistance; a step of transitioning the hydrophobic material to a hydrophilic material within 30 days of contact with the fluid, wherein the transition forms a variable flow resistance of the material that decreases from the first flow resistance to a second flow resistance lower than the first flow resistance; and a step of draining the reservoir by releasing the fluid through the hydrophilic material into the tissues surrounding the eye to relieve fluid pressure in the eye.
[0086] According to another embodiment of Example 79 ("Example 80"), the hydrophobic material and the hydrophilic material are microporous materials.
[0087] According to another embodiment of Example 80 ("Example 81"), the hydrophobic material is a microporous material in a hydrophobic state.
[0088] According to another embodiment of Example 80 ("Example 82"), the hydrophilic material is a microporous material in a hydrophilic state.
[0089] According to another embodiment of Example 80 ("Example 83"), the microporous material is initially in a hydrophobic state, and the transition of the hydrophobic material to the hydrophilic material changes the microporous material from a hydrophobic state to a hydrophilic state.
[0090] According to another embodiment of Example 83 ("Example 84"), a first portion of the microporous material transitions from a hydrophobic state to a hydrophilic state within 3 days.
[0091] According to another embodiment of Example 84 ("Example 85"), a second part of a microporous material different from the first part transitions from a hydrophobic state to a hydrophilic state within 7 days.
[0092] According to another example ("Example 86") regarding Example 83, the entire microporous material transitions from a hydrophobic state to a hydrophilic state within 30 days.
[0093] According to another embodiment of Example 83 ("Example 87"), in a hydrophobic state, the microporous material is opaque.
[0094] According to another example ("Example 88") regarding Example 83, in the hydrophilic state, the microporous material is transparent.
[0095] According to another embodiment of Example 79 ("Example 89"), the hydrophobic material has a maximum thickness of 500 μm or less.
[0096] According to another embodiment of Example 83 ("Example 90"), in the hydrophobic state, a water droplet placed on the surface of the microporous material forms a contact angle greater than 90 degrees with respect to the surface, and in the hydrophilic state, a water droplet placed on the surface of the microporous material forms a contact angle less than 90 degrees with respect to the surface. The transition from the hydrophobic state to the hydrophilic state results in a reduction of the contact angle by at least 10 degrees.
[0097] According to another embodiment of Example 83 ("Example 91"), the variable flow resistance is greater in the hydrophobic state than in the hydrophilic state.
[0098] According to another example ("Example 92") regarding Example 83, the microporous material is more translucent in the hydrophilic state than in the hydrophobic state.
[0099] According to another embodiment of Example 80 ("Example 93"), the method comprises the step of providing a continuous wall forming a reservoir and a reservoir opening in the continuous wall communicating with the reservoir—through which the conduit is interlockedly received. At least a portion of the continuous wall has a wall portion composed of a microporous material. The wall portion has an inner surface facing the reservoir and an outer surface on the opposite side facing an external region of the eye. The inner surface of the wall portion has a low-porous surface extending across the entire inner surface of the wall portion. The outer surface of the wall portion has alternating low-porous and high-porous surfaces.
[0100] According to another embodiment of Example 80 ("Example 94"), the microporous material comprises a first layer having a first microporous membrane integrated with a second microporous membrane and a second layer having a third microporous membrane integrated with a fourth microporous membrane.
[0101] According to another example ("Example 95") regarding Example 94, the microporous material comprises expanded polytetrafluoroethylene (ePTFE).
[0102] According to another embodiment of Example 95 ("Example 96"), the first microporous membrane permeability of the first microporous membrane is greater than the second microporous membrane permeability of the second microporous membrane. The fourth microporous membrane permeability of the fourth microporous membrane is greater than the third microporous membrane permeability of the third microporous membrane.
[0103] According to another embodiment of Example 96 ("Example 97"), the first layer and the second layer are laminated such that the first microporous membrane and the fourth microporous membrane are the outermost membranes of the shunt body, and the second microporous membrane and the third microporous membrane are the innermost membranes of the shunt body forming a reservoir.
[0104] According to another embodiment of Example 94 ("Example 98"), the first microporous membrane has first microporous membrane permeability, the second microporous membrane has second microporous membrane permeability, the third microporous membrane has third microporous membrane permeability, and the fourth microporous membrane has fourth microporous membrane permeability. The second microporous membrane permeability is approximately the same as the third microporous membrane permeability, and the first microporous membrane permeability is approximately the same as the fourth microporous membrane permeability. The second microporous membrane permeability and the third microporous membrane permeability are each different from the first microporous membrane permeability and the fourth microporous membrane permeability.
[0105] According to another embodiment of Example 94 ("Example 99"), the second and third microporous membranes are bonded together along the peripheral edges of the first and second layers to form a reservoir and place the reservoir between the second and third microporous membranes. The second and third microporous membranes are configured to resist tissue endogrowth. The first and fourth microporous membranes are configured to allow tissue endogrowth. The second and third microporous membranes have an extended state maintained adjacent to the peripheral edges of the first and second layers.
[0106] According to another embodiment of Example 94 ("Example 100"), the reservoir is configured to move between a contracted state in which the second and third microporous membranes resist fluid flow between them, and an expanded state in which fluid is allowed to flow between the second and third microporous membranes.
[0107] According to another embodiment of Example 100 ("Example 101"), fluid flow into the reservoir is directed from the distal end of the conduit toward the periphery of the chamber.
[0108] According to another embodiment of Example 100 ("Example 102"), the reservoir has a reservoir proximal section adjacent to the distal end of the conduit and a reservoir distal section positioned opposite the reservoir proximal section. During fluid discharge, the reservoir proximal section is configured to expand ahead of the reservoir distal section.
[0109] According to another embodiment of Example 83 ("Example 103"), the variable flow resistance corresponds to the rate of change of pressure with respect to the flow rate over time.
[0110] According to another embodiment of Example 103 ("Example 104"), the microporous material transitions from a hydrophobic state with a first flow resistance to a partially hydrophilic state with a second flow resistance, and subsequently to a hydrophilic state with a third flow resistance. The first flow resistance is greater than both the second flow resistance and the third flow resistance, and the second flow resistance is greater than the third flow resistance.
[0111] According to another embodiment of Example 83 ("Example 105"), the microporous material is configured to transition from a hydrophobic state to a hydrophilic state based on wetting of the microporous material by a fluid. The microporous material is configured such that wetting of the outer portion of the shunt body occurs prior to wetting of the reservoir.
[0112] According to another embodiment ("Example 106"), a method for managing fluid pressure in an eye is disclosed. The method comprises: identifying an undesirable fluid pressure in the eye with respect to ocular fluid placed in the eye; expanding a reservoir adjacent to the eye with a conduit fluidically associated with the ocular fluid so as to deliver the ocular fluid to the reservoir and bring it into contact with the reservoir wall—wherein the reservoir wall comprises a material that transitions from an initial hydrophobic state to a hydrophilic state within 30 days of contact with the ocular fluid, and the transition from the hydrophobic state to the hydrophilic state forms a variable flow resistance of the material that decreases from an initial first flow resistance to a second flow resistance lower than the first flow resistance—; and draining the reservoir by sending the ocular fluid through the material to tissues surrounding the eye to improve the undesirable fluid pressure in the eye.
[0113] According to another embodiment of Example 106 ("Example 107"), the variable flow resistance provides sufficient flow resistance to maintain a minimum fluid pressure to alleviate the occurrence of a low intraocular pressure state after short-term surgery.
[0114] According to another embodiment ("Example 108") regarding Example 106 or 107, the material is a microporous material.
[0115] According to another embodiment of Example 108 ("Example 109"), a first portion of the microporous material transitions from a hydrophobic state to a hydrophilic state within 3 days.
[0116] According to another embodiment of Example 109 ("Example 110"), a second part of a microporous material different from the first part transitions from a hydrophobic state to a hydrophilic state within 7 days.
[0117] According to another embodiment of Example 108 ("Example 111"), the entire microporous material transitions from a hydrophobic state to a hydrophilic state within 30 days.
[0118] According to another embodiment of Example 108 ("Example 112"), in a hydrophobic state, the microporous material is opaque.
[0119] According to another embodiment of Example 108 ("Example 113"), in the hydrophilic state, the microporous material is transparent.
[0120] According to another embodiment of Example 108 ("Example 114"), the microporous material in the hydrophobic state has a maximum thickness of 500 μm or less.
[0121] According to another embodiment of Example 108 ("Example 115"), in the hydrophobic state, a water droplet placed on the surface of a microporous material forms a contact angle greater than 90 degrees with respect to the surface, and in the hydrophilic state, a water droplet placed on the surface of a microporous material forms a contact angle less than 90 degrees with respect to the surface. The transition from the hydrophobic state to the hydrophilic state results in a reduction of the contact angle by at least 10 degrees.
[0122] According to another embodiment of Example 106 ("Example 116"), the variable flow resistance is greater in the hydrophobic state than in the hydrophilic state.
[0123] According to another embodiment of Example 108 ("Example 117"), the microporous material is more translucent in the hydrophilic state than in the hydrophobic state.
[0124] According to another embodiment of Example 108 ("Example 118"), the reservoir wall forms a reservoir opening communicating with the reservoir, and a conduit is interlockedly received through the reservoir opening. At least a portion of the reservoir wall has a wall portion composed of a microporous material. The wall portion has an inner surface facing the reservoir and an outer surface on the opposite side facing the outer region of the eye. The inner surface of the wall portion has a low-porous surface extending across the entire inner surface of the wall portion. The outer surface of the wall portion has alternating low-porous and high-porous surfaces.
[0125] According to another embodiment of Example 108 ("Example 119"), the microporous material comprises a first layer having a first microporous membrane integrated with a second microporous membrane and a second layer having a third microporous membrane integrated with a fourth microporous membrane.
[0126] According to another embodiment of Example 108 ("Example 120"), the microporous material comprises expanded polytetrafluoroethylene (ePTFE).
[0127] According to another embodiment ("Example 121") relating to Example 120, the first microporous membrane permeability of the first microporous membrane is greater than the second microporous membrane permeability of the second microporous membrane, and the fourth microporous membrane permeability of the fourth microporous membrane is greater than the third microporous membrane permeability of the third microporous membrane.
[0128] According to another embodiment of Example 121 ("Example 122"), the first layer and the second layer are laminated such that the first microporous membrane and the fourth microporous membrane are the outermost membranes of the shunt body, and the second microporous membrane and the third microporous membrane are the innermost membranes of the shunt body forming a reservoir.
[0129] According to another embodiment of Example 119 ("Example 123"), the first microporous membrane has first microporous membrane permeability, the second microporous membrane has second microporous membrane permeability, the third microporous membrane has third microporous membrane permeability, and the fourth microporous membrane has fourth microporous membrane permeability. The second microporous membrane permeability is approximately the same as the third microporous membrane permeability, and the first microporous membrane permeability is approximately the same as the fourth microporous membrane permeability. The second microporous membrane permeability and the third microporous membrane permeability are each different from the first microporous membrane permeability and the fourth microporous membrane permeability.
[0130] According to another embodiment of Example 119 ("Example 124"), the second and third microporous membranes are bonded together along the peripheral edges of the first and second layers to form a reservoir and place the reservoir between the second and third microporous membranes. The second and third microporous membranes are configured to resist tissue endogrowth. The first and fourth microporous membranes are configured to allow tissue endogrowth. The second and third microporous membranes have an extended state maintained adjacent to the peripheral edges of the first and second layers.
[0131] According to another embodiment of Example 119 ("Example 125"), the reservoir is configured to move between a contracted state in which the second and third microporous membranes resist fluid flow between them, and an expanded state in which fluid is allowed to flow between the second and third microporous membranes.
[0132] According to another embodiment of Example 125 ("Example 126"), fluid flow into the reservoir is directed from the distal end of the conduit toward the periphery of the chamber.
[0133] According to another embodiment of Example 125 ("Example 127"), the reservoir has a reservoir proximal section adjacent to the distal end of the conduit and a reservoir distal section positioned opposite the reservoir proximal section. During fluid discharge, the reservoir proximal section is configured to expand ahead of the reservoir distal section.
[0134] According to another embodiment of Example 108 ("Example 128"), the variable flow resistance corresponds to the rate of change of pressure with respect to the flow rate over time.
[0135] According to another embodiment of Example 128 ("Example 129"), the microporous material transitions from a hydrophobic state with a first flow resistance to a partially hydrophilic state with a second flow resistance, and subsequently to a hydrophilic state with a third flow resistance. The first flow resistance is greater than both the second flow resistance and the third flow resistance, and the second flow resistance is greater than the third flow resistance.
[0136] According to another embodiment of Example 108 ("Example 130"), the microporous material is configured to transition from a hydrophobic state to a hydrophilic state based on wetting of the microporous material by a fluid. The microporous material is configured such that wetting of the outer portion of the shunt body occurs prior to wetting of the reservoir.
[0137] The foregoing embodiments are merely examples and should not be construed as limiting or otherwise narrowing the scope of any inventive concept otherwise provided by this disclosure. Although numerous embodiments are disclosed, other embodiments will become apparent to those skilled in the art from the following detailed description, which presents and describes exemplary embodiments. Accordingly, the drawings and detailed description should be regarded as illustrative rather than limiting in nature. Brief explanation of the drawing
[0138] The filed patent application or the present application cites and claims priority to U.S. Application No. 17 / 980,417 filed on November 3, 2022, which includes at least one drawing made in one color. The attached drawings are included to provide further understanding of the present disclosure, are included in the specification and constitute part of the specification, and serve to illustrate embodiments and explain the principles of the present disclosure together with the detailed description. FIG. 1a shows an eye in which an exhaust system according to various aspects of the present disclosure is implanted therein; FIG. 1b shows a cross-section of detailed A1 from FIG. 1a; FIG. 1c is a schematic diagram of the implanted discharge device in detail A2 of FIG. 1b; FIG. 2a is a side view of a drainage system in the form of a glaucoma shunt according to various embodiments of the present disclosure; FIG. 2b is a bottom view of the discharge system of FIG. 2a; FIG. 2c is a cross-sectional view of the drainage system of FIG. 2a taken in section BB when the drainage system is in a contracted state and has a conjunctival tab; FIG. 2d is a cross-sectional view of the discharge system (100) of FIG. 2a taken in section CC when the discharge system is in a contracted state and has a first layer and a second layer with different microstructures and thicknesses; FIG. 2e is a perspective view of an alternative miniature embodiment of the exhaust system (100) of FIG. 2a; FIG. 3a is a schematic diagram of the wall of the discharge device in a contracted state; FIG. 3b is a schematic diagram of the wall of an expanded discharge device; FIG. 3c is an SEM image of a portion of the microstructure schematically illustrated in the exhaust system of FIG. 3a and FIG. 3b, the SEM image being of the scale as illustrated; FIG. 4a is a flowchart of a manufacturing method according to various embodiments of the present disclosure; FIG. 4b is a flowchart of a method of use according to various embodiments of the present disclosure; FIGS. 5a and FIGS. 5b (prior art) are a schematic plan view and a side view, respectively, of a conventional Ahmed glaucoma valve device for glaucoma drainage; FIG. 6a (prior art) is a top view photograph of a prior art Ahmed glaucoma valve modified with a polyethylene shell and implementing a solid plate as known in the art; FIG. 6b (prior art) is a photograph of a side view of the prior art glaucoma valve of FIG. 6a in which a portion of the solid plate is removed to show the reservoir located therein; FIG. 6c (prior art) is an SEM image of a portion of the surface of a solid plate used in the glaucoma valve of the prior art of FIG. 6a; FIGS. 7a and 7b are schematic side views of the sessile drop method performed on a surface; FIGS. 8a through 8e are backlight microscope images of an exhaust device in various states during a transition from a hydrophobic state to a hydrophilic state according to various embodiments of the present disclosure; FIGS. 9a through 8c are microscopic images of an exhaust device in various states during a transition from a hydrophobic state to a hydrophilic state according to various embodiments of the present disclosure; FIG. 10 is a graph comparing flow rate versus pressure in three different periods during wetting; FIG. 11a is a graph comparing the percentage of device flow resistance during wetting; Figure 11b is a graph comparing the percentage of the area of the device that is wetted during wetting. Specific details for implementing the invention
[0139] Definitions and Terms
[0140] The present disclosure is not intended to be understood in a restrictive manner. For example, terms used in this application should be understood broadly in the context of the meanings attributed to them by those skilled in the art.
[0141] With respect to the term inaccuracy, the terms “approximately” and “roughly” may be used interchangeably to denote a measurement that includes the specified measurement and any measurement that is reasonably close to the specified measurement. A measurement that is reasonably close to the specified measurement deviates from the specified measurement by a reasonably small amount, as understood and readily verifiable by a person of ordinary knowledge in the relevant art. Such deviation may be attributed, for example, to measurement errors, differences in measurement and / or manufacturing equipment calibration, human error in reading and / or setting the measurement, other components, specific implementation scenarios, inaccurate adjustment and / or manipulation of the object by a person or machine, or minor adjustments made to optimize performance and / or structural parameters in consideration of the difference in the measurement. Where it is determined that a person of ordinary knowledge in the relevant art cannot readily verify the value of such a reasonably small difference, the terms “approximately” and “roughly” may be understood to mean plus or minus 10% of the specified value.
[0142] Description of various embodiments
[0143] Those skilled in the art will readily understand that various aspects of the present disclosure may be implemented by any number of methods and devices configured to perform the intended functions. It should also be noted that the accompanying drawings referenced herein are not necessarily drawn in a fixed proportion and may be exaggerated to illustrate various aspects of the present disclosure, and in this regard, the drawings should not be interpreted as limiting.
[0144] The device illustrated in FIGS. 5a and 5b is an Ahmed glaucoma valve model FP7 (New World Medical, Inc., Rancho Cucamonga, California) having a maximum thickness of 2.1 mm, a silicone plate, a silicone drainage tube, a silicone valve membrane, and a polypropylene (PP) valve casing. The Ahmed device comprises a plate body ("body") forming a surface over which the drained fluid (aqueous humor) is guided and flows, and a drainage tube ("tube") guiding the fluid (aqueous humor) to flow over the surface of the plate body. The plate body has a maximum thickness ("thickness") and is manufactured of medical-grade silicone, which is rigid and lacks the flexibility to conform to the curvature of the eye when implanted. Accordingly, the plate body has a curvature (defined by the dotted line CC) that is made to be close to the curvature of the surface of the eye (i.e., formed prior to implantation). The curvature CC is fixed and identical for all similarly designed Ahmed glaucoma devices, and consequently, in some cases, it may not adapt to the unique curvature of each patient's eye. Additionally, to regulate fluid pressure, the device requires the inclusion of a mechanical valve structure ("valve") that does not degrade and does not biodegrade to control fluid pressure within the device over a long period (e.g., years). In certain examples known in the art, the valve can be closed when the pressure exceeds a threshold, such as 7 mmHg, to reduce the risk of postoperative hypotension-related complications. As illustrated, the valve has a specific thickness and stiffness that determine the thickness of the device; consequently, when the device is implanted, it lacks the flexibility to adapt to the curvature of the eye, and the thickness of the plate body increases.
[0145] Although the Ahmed glaucoma valve is designed to maintain constant flow resistance for years, Choudhari et al. "Is Ahmed Glaucoma Valve Consistent in Performance?" (Translational Vision Science & Technology. 2018 Jun 22;7(3):19. doi: 10.1167 / tvst.7.3.19. PMID: 29946493; PMCID: PMC6016431); Moss et al. "Assessment of closing pressure in silicone Ahmed FP7 glaucoma valves." (Journal of Glaucoma. 2008 Sep;17(6):489-93. doi: 10.1097 / IJG.0b013e3181622532. PMID: 18794686); and Bochmann et al. "Intraoperative testing of opening and closing pressure predicts risk of low intraocular pressure after Ahmed According to articles such as "glaucoma valve implantation." (Eye (Lond). 2014 Oct;28(10):1184-9. doi: 10.1038 / eye.2014.168. Epub 2014 Jul 25. PMID: 25060848; PMCID: PMC4194337), it is understood that the functionality and performance of a device as a valve may change as the flow rate decreases over a long period of time.
[0146] FIGS. 6a through 6c illustrate other examples of glaucoma drainage devices known in the art. A device as illustrated comprises two solid plates, such as those made of silicone as illustrated in FIGS. 5a and 5b, which form two layers (“L1” and “L2”) to receive fluid from the anterior chamber (AC) of the eye and store the fluid within an inner chamber formed between the plates. The device illustrated in FIGS. 6a and 6b is described in Kim et al.’s “Clinical experience with a novel glaucoma drainage implant.” As previously disclosed in (Journal of Glaucoma. 2014 Feb; 23(2):e91-7. DOI: 10.1097 / ijg.0b013e3182955d73. PMID: 23689073), the Ahmed glaucoma valve model M4 (New World Medical, Inc., Rancho Cucamonga, California) has a polyethylene shell to reduce the fibrotic reaction around the drainage plate compared to the S2 and FP7 models in patients with glaucoma. The device of the prior art is manufactured with a tube ("tube") installed between two layers (L1 and L2) of a solid material such as a porous polyethylene shell (e.g., Medpor) that follows the curvature of the eye, a reservoir ("R") is formed between the two layers (L1 and L2), and the tube guides fluid from the eye into the reservoir. As shown in the prior art device of FIG. 6c, scaled so that the black bar at the bottom of the drawing represents 500 μm, the surface of the layers (L1 and L2) includes pores to improve tissue integration so that adjacent tissues can be integrated with the polyethylene shell surrounding the discharge device, as well as to ensure that the fluid stored inside the reservoir (R) is released back into the surrounding tissues to prevent excessive stress on the surrounding tissues.
[0147] However, unlike the various embodiments described herein, implanting a member of a solid or hard material (i.e., a material lacking flexibility and thinness) into the eye, as illustrated in FIG. 6a and FIG. 6c, increases the stress applied to the eye, particularly within the conjunctival tissue of the eye, when pressure is applied from the anterior chamber of the eye, which can cause discomfort and other complications resulting from increased pressure extending into this sensitive area of the eye.
[0148] Various features of the device, system, and method disclosed herein can be seen in FIGS. 1a–1c. An aspect of the present disclosure relates to a drainage device, system, and method for biological fluids. More specifically, the present disclosure relates to a device, system, and method for draining aqueous humor from the anterior chamber (AC) of a patient's eye (10) so that the aqueous humor can be reabsorbed elsewhere in the body. To this end, FIG. 1a is an example of an eye (10) having a subconjunctival space (11) between the sclera (15) and the conjunctiva (13) of the eye (10). A drainage system (100) according to the principles of the present disclosure is implanted in the eye (10). FIG. 1b shows a cross-sectional view of detail A1 from FIG. 1a. FIG. 1c shows a schematic diagram of the implanted drainage device in detail A2 of FIG. 1b. In an embodiment of the present disclosure, a mechanism is provided for reabsorbing aqueous humor discharged from the anterior chamber (AC) of the eye (10) to reduce or otherwise stabilize intraocular pressure. However, those skilled in the art will understand that an embodiment of the present disclosure is useful for other uses where discharge of biological fluid is desired to be redirected into the body.
[0149] The drainage system (100) illustrated in FIGS. 1a-1c includes a drainage device (110) for treating glaucoma. As illustrated herein, such a glaucoma drainage device (110) has a wall (112) having a first side (114) and a second side (116) (best identifiable in FIGS. 1b and 1c). Although the suction conduit (120) is discussed below, it should be understood that the drainage device (110) may be a standalone product insofar as a part thereof is configured to receive fluid (e.g., directly from an incision, from a fluid conduit (120), etc.), and thus should not be considered outside the scope of the present disclosure. The suction conduit (120) may be coupled to the drainage device (110) in a fluid relationship. Upon implantation, the suction conduit (120) extends from the anterior chamber (AC) of the eye (10) to the drainage device (110). At this time, the water in the front room (AC) flows into the discharge device (110) through the suction conduit (120).
[0150] The choice of material for the exhaust device (110) can contribute to the functionality of the exhaust device and a relatively low profile compared to other devices known in the art. The exhaust device (110) may include biocompatible materials, including microporous materials such as expanded polytetrafluoroethylene (ePTFE), as described below. The suction conduit (120) may include flexible biocompatible materials suitable for use in constructing slender members. Some such suitable materials include silicone, polytetrafluoroethylene, polypropylene, polymethyl methacrylate, acrylic, polyurethane, silastic, and metal. Such a configuration of the exhaust system (100) is particularly useful for surgical implants.
[0151] Generally, the surgical implantation of a drainage device, such as a drainage system (100), carries the risk of abnormal pressure within the eye (10). For example, when a drainage device is surgically implanted, such as in a surgery that requires creating a bleb under the outer surface tissue of the eye (10) [i.e., the conjunctiva (13)] [as indicated by the dotted line around the device (110)], the surrounding tissue fresh from the surgical injury does not provide significant flow resistance to the aqueous humor flow until sufficient wound healing occurs. During this early postoperative period, the patient is at risk of hypointraocular pressure (e.g., excessively low intraocular pressure) in the eye (10). To avoid hypointraocular pressure, measures are taken to manage the flow through the drainage device (110) for a specified period. For example, the surgeon typically 'ties' a portion of the suction duct (120) near the proximal end for a specified period and unties it after sufficient surgical wound healing has progressed so that the surrounding tissue provides the necessary flow resistance. In certain commercially available glaucoma shunt devices, a limiting flow 'valve' is added to the distal end of the suction conduit (120) where the plate section is located. However, such devices are relatively rigid and bulky and can still result in low intraocular pressure. In contrast, advantageously, a drainage device, system, and method according to the principles of the present disclosure include a low-profile device without a valve that creates distinct flow resistance during the early postoperative period (known as the postoperative wound healing period, which may continue for about 30 days after surgery) in order to avoid low intraocular pressure by changing the flow resistance over time, for example, from a high-resistance state with hydrophobic characteristics to a low-resistance state with hydrophilic characteristics over a period of time, for example, 30 days.
[0152] Referring to FIGS. 1b and 1c, a non-limiting exemplary implantation of the drainage system (100) is illustrated. In this example, the drainage system (100) is illustrated as being placed in the subconjunctival space (11) between the sclera (15) and the conjunctiva (13) of the eye (10). The drainage system (100) is illustrated as being oriented such that the first layer (114) extends along the sclera (15) and the second layer (116) extends along the conjunctiva (13). It will be understood that the portion of the second layer (116) in contact with the conjunctiva (13) may be configured to promote or allow tissue-independent growth, as described below. Additionally, it will be understood that the portion of the first layer (114) in contact with the sclera (15) may be configured alternatively or additionally to promote or allow tissue-independent growth, as described below. This configuration contributes to minimizing relative movement between the discharge device (110) and the surrounding tissue.
[0153] Additionally, in FIGS. 1b and 1c, the suction conduit (120) is shown extending from the discharge device (110) and extending through a scleral access, perforation, or hole (H) (e.g., formed by a physician during the implantation procedure according to a known method) so that the first end (122) (e.g., proximal end) enters the anterior chamber (AC) and the port (271) is in communication with the anterior chamber. In some embodiments, when implanted, the aqueous humor enters the first end (122) of the suction conduit (120) and moves to the second end (124) (e.g., distal end) of the suction conduit (120) which is in fluid communication with the discharge device (110). The wall (112) and the suction conduit (120) together may form a flow path (140), and the drainage flows through the discharge device (110) along this flow path. In some embodiments, a second end (124) is positioned within the discharge device (110) so that the removed aqueous humor enters a reservoir (130) formed within the discharge device (110) and penetrates various dispersion membranes of the discharge device (110), after which the aqueous humor can be absorbed by surrounding tissue and / or inward-growing tissue.
[0154] Referring to FIGS. 2a through 2e, various embodiments of an exemplary drainage system (100) in the form of a glaucoma shunt (110) are illustrated. FIG. 2a illustrates a side view of the drainage system (100). FIG. 2b illustrates a bottom view of the drainage system of FIG. 2a. FIG. 2c illustrates a cross-sectional view of the drainage system (100) of FIG. 2a taken at section BB of the drainage system (100) in a contracted, contracted, or discharged state in which an internal fluid, such as biological fluid, is discharged from the drainage system (100) [or more specifically, the reservoir (130)]. This drainage system (100) illustrates a conjunctival tab to prevent erosion of the conjunctiva (13) by the conduit (120), a neck to which the conduit (120) is bonded to a wall (112) (e.g., via adhesive in “b”), and a reservoir (130) at the distal end of the conduit (120). FIG. 2d illustrates a cross-sectional view of the drainage system (100) of FIG. 2a taken from section CC of the drainage system (100) in a contracted or retracted state. FIG. 2e illustrates a perspective view of an alternative miniature embodiment of the drainage system (100) of FIG. 2a. Also, as in FIG. 1a-1c, the drainage system (100) here relates to draining biological fluid from one part of a patient's body to another. In particular, as long as fluid is allowed to escape from the distal end (124) of the conduit (120) and fill the reservoir (130), the conduit (120) may be inserted into the reservoir (130) at a variable depth, such as a shallow depth as shown in FIG. 2c or a main depth as shown in FIG. 2d. Such a device may have a low profile with distinct fluid flow resistance during the early postoperative period to avoid low intraocular pressure.
[0155] The drainage system (100), which is a glaucoma shunt (110) illustrated in these drawings, is useful for draining biological fluid from the eye. This drainage can proceed from a part inside the eye (e.g., anterior chamber) to surrounding tissues outside the eye. The drainage device (110) may include a wall (112) forming a reservoir (130) placed within the wall (112). The reservoir (130) may be configured to be in fluid communication with the eye to receive drainage flowing from a part inside the eye toward the reservoir (130). The wall (112) may be integrated into the body of the drainage device (110) or may entirely form the body of the drainage device (110). In this regard, the body may have a wall (112) forming an internal storage (130) within the body and an internal storage opening disposed in the wall (112) to communicate with the internal storage (130) (e.g., in the adhesive 'b' in FIG. 2c or around it). As is often described herein, such a wall (112) is continuous [e.g., a continuous wall (112)], but other types of walls (112) in which discontinuities are sealed are also considered.
[0156] According to some embodiments, a user can identify undesirable fluid pressure in the eye regarding ocular fluid placed inside the eye. The user can expand the reservoir adjacent to the eye via a conduit fluidically associated with the ocular fluid so that the ocular fluid is delivered to the reservoir (130) and comes into contact with a reservoir wall (112) comprising a material that transitions from an initial hydrophobic state to a hydrophilic state within 30 days of contact with the ocular fluid. The transition from the hydrophobic state to the hydrophilic state forms a variable flow resistance of the material that decreases from an initial first flow resistance to a second flow resistance lower than the first flow resistance. Subsequently, the reservoir (130) can be drained by sending the ocular fluid through the hydrophilic material to the tissues surrounding the eye to improve the undesirable fluid pressure in the eye. The hydrophilic material may be a wall (112) that is in a hydrophilic state as described herein.
[0157] The wall (112) may comprise a microporous material that transitions from a hydrophobic state to a hydrophilic state. In embodiments, the wall (112) is configured to provide variable flow resistance as it transitions from a hydrophobic state to a hydrophilic state. The discharge device (110) may include a channel (140) configured to facilitate the discharge of biological fluid from a portion inside the eye to surrounding tissue outside the eye. In particular, the channel (140) may include variable flow resistance for the drainage passing through the channel (140). The channel (140) may have a first flow resistance portion having a first flow resistance and a second flow resistance portion having a second flow resistance. Optionally, as described in more detail below, the first flow resistance may be different from the second flow resistance.
[0158] The wall (112) may be a multilayer structure comprising one or more microstructures. The wall (112) may also be a continuous single-layer structure comprising a plurality of sub-layers within a continuous single-layer structure, or a continuous single-layer structure capable of forming both sides of a continuous single-layer structure that exhibit a first porosity on a first side of the single-layer structure and a second porosity on a second side of the single-layer structure. In this regard, embodiments of the wall (112) may include a first layer (114) having a first microporous membrane (241) coupled with a second microporous membrane (242) and a second layer (116) having a third microporous membrane (243) coupled with a fourth microporous membrane (244). In many examples, such combination between the first microporous membrane (241) and the second microporous membrane (242), and between the third microporous membrane (243) and the fourth microporous membrane (244), is a combination in which the first and second microporous membranes (241, 242) and the third and fourth microporous membranes (243, 244) are each formed integrally with one another. In certain examples, the first and second layers (114, 116) may comprise a nearly microporous membrane, some of which is described in U.S. Application No. 15 / 922,692, filed March 15, 2018, titled “Integrated aqueous shunt for glaucoma treatment,” the full contents of which are incorporated herein by reference.
[0159] Providing various microporous materials within a continuous single-layer structure can facilitate the operation of the reservoir (130). As fluid flows into the reservoir (130), the fluid may come into contact with the microporous material of the wall (112). In certain situations, the second and third microporous membranes (242, 243) are joined together along the peripheral edge (247) of the discharge device (110). For example, the second and third microporous membranes (242, 243) may be joined at the periphery of the first and second layers (114, 116) to form a reservoir (130) positioned between the second microporous membrane (242) and the third microporous membrane (243). This joining may be a joint that is a hermetic sealing joint ensuring the structural integrity of the reservoir (130). In a specific example, in order to initially expand the reservoir (130), the second and third microporous membranes (242, 243) may initially be in contact with each other or very close to each other so that fluid can come into contact with the interface between the second microporous membrane (242) and the third microporous membrane (243). In this regard, initially and thereafter, the reservoir (130) may be configured to move between a contracted state (or alternatively a contracted state, discharged state, or discharged state) in which the second and third microporous membranes (242, 243) resist fluid flow between them, and an expanded state (or alternatively an expanded state) in which fluid is allowed to flow between the second and third microporous membranes (242, 243). In certain examples, the first and fourth microporous membranes (241, 244) may be kept unbonded to each other, whereas in other examples, it may be useful to bond the first and fourth microporous membranes to each other [e.g., bonding the second and third microporous membranes (242, 243) together].
[0160] The wall portion has an initial hydrophobic state, and when a biological fluid comes into contact with the wall portion, the initial hydrophobic state transitions to a final hydrophilic state. In one embodiment, a first sub-layer within the wall portion has a first initial hydrophobic state, which transitions to a first final hydrophilic state at a greater rate than another second sub-layer within the wall portion transitioning from a second initial hydrophobic state to a second final hydrophilic state. In some embodiments, when the wall portion is in a hydrophilic state, drainage and emptying of the reservoir may occur. For example, during initial filling, the first layer and the second layer may be gradually separated by the inflow of drainage fluid filling the reservoir formed between the first layer and the second layer. When fluid from the drain comes into contact with the inner surface (251) of the wall portion, due to the low porosity of this inner surface, the microporous material on this inner surface may take a long time to wet, but may be completely wetted in the proximal portion of the reservoir before complete wetting in the distal portion of the reservoir. At the same time, tissue growth penetrates the microstructure on the outer surface (253) of the wall portion until it reaches a region of low porosity, such as the inner surface (251) of the wall portion. Since the outer surface (253) of the wall portion has higher porosity than the inner surface (251) of the wall portion, fluid from the surrounding tissue may begin to wet the outer surface (253) of the wall portion faster than the drain in the reservoir. This action creates a gradient across the thickness of the microstructure, where certain parts of the microporous material (e.g., highly porous parts) in this microstructure wet faster than other parts and transition from hydrophobic to hydrophilic. Generally, this gradient will be a gradient in which the inner surface (251) of the wall portion undergoes the aforementioned transition later than the outer surface (253) of the wall portion (and thereby provides a variable, greater flow resistance).Eventually, as both the inner surface (251) and the outer surface (253) of the wall portion become hydrophilic, the gradient mentioned above will be dissipated through the microporous material to a significantly constant level in some embodiments.
[0161] The arrangement configuration of the microporous material forming the wall (112) may be such that wetting of the microporous material is promoted on the outer surface (253) of the wall (112) prior to the inner surface (251) of the wall (112). In this regard, the inner surface (251) of the wall (112) may form a reservoir (130). In the embodiments, the first layer (114) and the second layer (116) are arranged in a stacked configuration such that the first microporous membrane (241) and the fourth microporous membrane (244) are the outermost membranes of the wall (112), and the second microporous membrane (242) and the third microporous membrane (243) are the innermost membranes of the wall (112).
[0162] In the embodiments, the microporous material may comprise ePTFE. In this regard, the microporous material may be configured to transition from a hydrophobic state to a hydrophilic state based on wetting of the microporous material by a biological fluid, and the microporous material is configured such that wetting of the outer portion of the wall (112) occurs prior to wetting of the surface forming the reservoir (130). In the embodiments, the hydrophilic state promotes tissue growth. In some of these embodiments, the hydrophilic state may form a first aspect of the microporous material, and the hydrophobic state may form a second aspect of the microporous material. Additionally, other materials similar to ePTFE are considered. These other materials may include polymers such as, but not limited to, polyethylene, polyurethane, polysulfone, polyvinylidene fluorine (PVDF), polyhexafluoropropylene (PHFP), perfluoroalkoxy polymer (PFA), polyolefin, fluorinated ethylene propylene (FEP), acrylic copolymer, and other suitable fluorocopolymers.
[0163] Drainage from a portion inside the eye may perfuse the discharge device (110) through a flow path (140), such as illustrated in FIG. 1c and FIG. 2d, but also shown in other drawings as forming a tube and / or reservoir that allows fluid to reach the device. The flow path (140) may include a portion (e.g., part or all) of the wall (112) and optionally may include a suction conduit (120) as described in more detail below. In this regard, in one embodiment, fluid may flow into the reservoir (130) through the flow path (140) after being received through the suction conduit (120) or directly into the wall (112), and then flow out of the reservoir (130). For example, in a first example of a reservoir (130) filled with biological fluid, the reservoir (130) may gradually move from a contracted state (contracted state) toward an expanded state (extended state). In this case, the biological fluid may remain in the reservoir (130) until parts of the wall (112) transition from a hydrophobic state to a hydrophilic state. In these examples, the biological fluid may penetrate the wall (112) [e.g., from the inner surface (251) of the wall (112) to the outer surface (253) of the wall (112) or the surrounding edge] so that the flow changes from the wall (112) toward the surrounding part of the body.
[0164] In an embodiment in which bonding can be used partially or wholly to fix the membranes together, bonding of the microporous material may exist at the peripheral edges (261, 262, 263, 264) of the microporous membranes (241, 242, 243, 244) in the discharge device (110). In particular, the first microporous membrane (241) is shown as having a first peripheral edge (261), the second microporous membrane (242) is shown as having a second peripheral edge (262), the third microporous membrane (243) is shown as having a third peripheral edge (263), and the fourth microporous membrane (244) is shown as having a first peripheral edge (264). As implied above, any combination of these microporous membranes (241, 242, 243, 244) may be joined at their respective peripheral edges (261, 262, 263, 264). In the embodiments, the second and third microporous membranes (242, 243) are joined at their peripheral edges (262, 263) to form a reservoir (130) between the second microporous membrane (242) and the third microporous membrane (243). In some of these embodiments, the first and fourth microporous membranes (241, 244) are not joined at the second and third peripheral edges (262, 263) of the second and third microporous membranes (242, 243), respectively. In some of these embodiments, the first and fourth microporous membranes (241, 244) are not joined to each other, either partially or wholly. In any of these examples, the joining at the peripheral edges (261, 262, 263, 264) of the microporous membranes (241, 242, 243, 244) may be a sealing joining and may optionally accommodate an additional structure, such as a suction conduit (120), and be sealing joined to the discharge device (110).In an alternative embodiment similar to the above-described embodiment, the bonding may be applied as described, except between the first membrane (241) and the second membrane (242), which can be replaced by a single integrated layer having a sub-layer having the characteristics of the first and second membranes, and likewise between the third membrane (243) and the second membrane (244), which can be replaced by a single integrated layer having a sub-layer having the characteristics of the third and fourth membranes.
[0165] In particular, at least a portion of the continuous wall (112) may have a wall portion [e.g., part or all of the wall (112)] composed of a microporous material. The wall portion may have an inner surface (251) of the wall portion facing the internal storage (130) and an outer surface (253) of the wall portion opposite the inner surface (251) of the wall portion and facing the outer area of the human eye. The inner surface (251) of the wall portion may have a low-porous surface extending over the entire inner surface (251) of the wall portion. The outer surface (253) of the wall portion may have an alternating surface comprising a low-porous surface positioned between high-porous surfaces.
[0166] The above conduit (120) may be positioned to extend from the body by the length of the conduit. The conduit (120) has a first end (122) and a second end (124) opposite each other, and forms a passage through the conduit such that a passage extends between the first end (122) and the second end (124) opposite each other. The first end (122) of the conduit may engage with an internal reservoir opening to provide a fluid connection between the second end (124) of the conduit and the internal reservoir (130). The length of the conduit may be sufficient to position the first end (122) of the conduit in the outer region of the human eye and the second end (124) of the conduit in the inner region of the human eye. In the embodiments, the fluid connection between the second end (124) of the conduit and the internal reservoir (130) is further extended from the internal reservoir (130) through a microporous material to provide fluid communication from the internal reservoir (130) to an area outside the human eye. The fluid communication may form a flow path through the microporous material. Additionally, as described below, the flow path through the microporous material may be in a direction away from the internal reservoir (130) and / or proceed from a low-porous microporous region to a high-porous microporous region.
[0167] Various features of other embodiments of the discharge system (100) according to various aspects of the present disclosure are illustrated in FIG. 2e. In particular, as with other discharge devices discussed elsewhere in the present invention, FIG. 2e illustrates a discharge system (100) comprising a reservoir (130) having a wall (112) formed therein and a suction conduit (120) in fluid communication with the reservoir (130). Also, as with FIG. 1a-1c and FIG. 2a-2d, the discharge system (100) herein relates to discharging biological fluid from one part of a patient's body to another. Such a device may have a low profile having distinct fluid flow resistance during the early postoperative period to avoid low intraocular pressure. Such a device (110) may be smaller in size (e.g., any one or more dimensions including length, width, and thickness) and thus may be more suitable for a patient smaller than the device (110) of FIG. 2a-2d. In some embodiments, the thickness of the device (110) [i.e., the maximum thickness of the shunt or shunt body (110)] is about 25 µm to about 30 µm, about 30 µm to about 40 µm, about 40 µm to about 50 µm, about 50 µm to about 60 µm, about 60 µm to about 70 µm, about 70 µm to about 80 µm, about 80 µm to about 90 µm, about 90 µm to about 100 µm, about 100 µm to about 150 µm, about 150 µm to about 200 µm, about 200 µm to about 250 µm, about 250 µm to about 300 µm, about 300 µm to about 350 µm, about 350 µm to about 400 µm, about 400 µm It may be in the range of about 450 μm to about 450 μm, or from about 450 μm to about 500 μm, or any other suitable value or range between the above ranges and / or a combination of these ranges.
[0168] The exhaust system (100) illustrated herein is similar in many respects to the exhaust system described above. For example, the exhaust system (100) illustrated herein may include first and second layers as described with respect to FIGS. 2a–2d. These layers are joined around the suction conduit (120) (e.g., in second and third microporous membranes) similarly to those described with respect to FIGS. 1a–1c. Although illustrated as extending to a specific location, the distal end of the suction conduit (120) may be positioned to be in a flow relationship with the reservoir (130) [e.g., positioned more proximal or distal than illustrated, floating between the inner surface of the reservoir (130), or positioned along the inner surface of the reservoir]. Other variations will be apparent to those skilled in the art.
[0169] As mentioned above, discharge from the portion inside the eye to the reservoir (130) can be facilitated by creating a flow path between them. An exemplary means for creating such a flow path is via a suction conduit (120). The suction conduit (120) may optionally be a hollow member such as a slender and flexible shunt. The suction conduit (120) may be positioned to be in fluid communication with the reservoir (130) and optionally to be in a sealing connection with the reservoir. In this regard, the suction conduit (120) may have a second end communicating with the reservoir (130) and a first end on the opposite side forming a port. Accordingly, the first end may be a proximal end of the suction conduit (120), and the second end may be a distal end of the suction conduit (120). The suction tube (120) can be configured to be placed inside the eye to facilitate discharge from a part inside the eye, through a port, and into a reservoir (130).
[0170] Additional configurations of a Euro having a variable resistor are described in detail in U.S. Provisional Application No. 63 / 276,183, titled “BIOLOGICAL FLUID DRAINAGE DEVICES, SYSTEMS, AND METHODS”, filed on November 5, 2021 (Agent Case No.: 450385.003251 2400Us01), the full disclosure of which is incorporated herein by reference in its entirety.
[0171] Now, details of the microporous material will be discussed with reference to FIGS. 3a–3c. For clarity, these drawings omit the illustration of the conduit, but as discussed elsewhere in this invention, it is understood that the conduit may be arranged in fluid communication with the reservoir (130). In particular, FIGS. 3a and 3b illustrate cross-sectional views of the wall (112) of the discharge system in which the reservoir (130) is placed along the middle section of the width of the discharge system. More specifically, FIG. 3a illustrates a discharge device in a contracted or discharged state [with little or no fluid in the reservoir (130)]; FIG. 3b illustrates a discharge device in an expanded state [with fluid collected in the reservoir (130) to expand the reservoir (130)]. In some embodiments, the expanded state may be when the wall (112) of the reservoir (130) is in a hydrophobic state, and the discharged state may be when the wall (112) of the reservoir (130) is in a hydrophobic state, and as a result, the discharge of the fluid inside the reservoir (130) may occur in a hydrophilic state or as a transition from a hydrophobic state to a hydrophilic state as described herein. FIG. 3c is a close-up view of the microstructure in the discharge system of FIG. 3a and FIG. 3b. "5.00kV 4.2mm x500 SE 1 / 23 / 2018" is marked on the bottom of FIG. 3c, and the distance between two consecutive lines as shown in the right corner of the bottom is 10 μm.
[0172] Referring to FIGS. 3a and 3b, a microstructure through which biological fluid penetrates may be contained within a portion (e.g., part or all) of a microporous material. For the microporous material to be a multi-membrane material, the microstructure may contain multiple deposits of microporous membranes within it. Grouped or combined deposits of microporous material may form a layer of microporous material, which may be overlapped, folded, or similarly arranged. In this situation, a reservoir (130) may have a reservoir proximal section (231) and a reservoir distal section (232), and the reservoir may disperse the collected fluid into surrounding tissue outside the wall (112).
[0173] Expansion of the reservoir (130) may occur in the unbonded portion of the wall (112). As mentioned above, the second and third microporous membranes (242, 243) may be bonded at the periphery so that their internal portions are not bonded. Since the aforementioned internal portions are not bonded, they are freely separated from each other (or one from the other) to allow the reservoir (130) to be filled with fluid. The reservoir (130) may have a reservoir proximal section (231) that may be positioned adjacent to the distal end of the suction conduit, as further discussed below, and a reservoir distal section (232) that is positioned opposite the reservoir proximal section (231). Fluid flow to (or into) the reservoir (130) may be directed from the distal end of the suction conduit toward the periphery of the chamber. In this regard, the reservoir proximal section (231) may be configured to expand ahead of the reservoir distal section (232).
[0174] Contact between the microporous material and the fluid can impart flow resistance, and as a result, pressure may be generated within the reservoir (130). For example, the second and third microporous membranes (242, 243) of the wall (112) may be located adjacent to each other and optionally in contact with each other. As the reservoir (130) is filled, the second and third microporous membranes (242, 243) are gradually separated by the fluid flowing into the reservoir (130). For example, since the inner surface of the reservoir (130) may initially be hydrophobic, the flow into the reservoir (130) increases the pressure and causes the reservoir (130) to expand (e.g., the second and third chambers move away from each other). When the wall (112) transitions from a hydrophobic state to a hydrophilic state and the fluid flow comes into contact with the reservoir (130), variable flow resistance may be imparted to the fluid flow. The above variable flow resistance can correspond to the rate of change of pressure with respect to flow rate over time. In embodiments, the wall (112) transitions from a hydrophobic state having a first flow resistance to a partially hydrophilic state having a second flow resistance to a hydrophilic state having a third flow resistance; the first flow resistance is greater than both the second flow resistance and the third flow resistance, and the second flow resistance is greater than the third flow resistance.
[0175] The rate at which the biological fluid disperses from the reservoir (130) through the wall (112) can be influenced by the flow rate, which increases as the flow resistance decreases. As the reservoir (130) expands and the microporous material transitions from a hydrophobic state to a hydrophilic state, the aforementioned dispersion may occur in several directions [e.g., radially outward from the reservoir (130) through unjoined parts of the surrounding edge, etc.]. If the flow into the reservoir (130) is smaller than the flow out of the reservoir (130), the reservoir (130) may move from the expanded state toward the contracted state. On the other hand, if the flow into the reservoir (130) is larger than the flow out of the reservoir (130), the reservoir (130) may move from the contracted state toward the expanded state. Assuming continuous flow into the reservoir (130), the reservoir (130) may be maintained in an expanded state, which is an intermediate state between the expanded state and the contracted state. In any of these examples, there is a pressure associated with the filling level and / or amount of flow of the reservoir (130). After the fluid is collected in the reservoir (130), the fluid can be dispersed through the wall (112) at varying flow rates depending on the transition state of the microporous material.
[0176] The permeability of each layer of the microporous material may vary depending on the dimensions (e.g., thickness or length) of the microstructure within it. In this situation, in certain examples, the permeability of the first microporous membrane (241) may be higher than the permeability of the second microporous membrane (242) of the second microporous membrane (242). Similarly, the permeability of the fourth microporous membrane (244) may be higher than the permeability of the third microporous membrane (243) of the third microporous membrane (243). In the embodiments, the permeability of the second microporous membrane (242) may be approximately the same as the permeability of the third microporous membrane (243). In the embodiments, the transmittance of the first microporous membrane (241) may be approximately the same as the transmittance of the fourth microporous membrane (244). In some of these embodiments, the transmittance of the second microporous membrane (242) and the transmittance of the third microporous membrane (243), respectively, are different from the transmittance of the first microporous membrane (241) and the transmittance of the fourth microporous membrane (244).
[0177] The pores of the membrane within the microporous material may be positioned to affect the tissue growth capacity in the corresponding portion. It may be desirable for tissue growth to occur in a portion of the wall (112) [e.g., on the outer surface (253) of the wall (112)] and to be resisted in another portion of the wall (112) [e.g., in the reservoir (130)]. Tissue growth on the outer surface (253) of the wall (112) can fix the device in the implantation position, and resistance to growth in the reservoir (130) can prevent the reservoir (130) from becoming unable to expand due to tissue growth across the reservoir (13). To achieve these functions, the porosity on one side of the microporous material may be greater than the porosity on the opposite side of the microporous material. In this regard, the microporous material may have a dense side (e.g., greater porosity) and a loose side (e.g., lower porosity). In the embodiments, the second and third microporous membranes (242, 243) may be configured to resist tissue-inhibitory growth. In some embodiments, the first and fourth microporous membranes (241, 244) are configured to allow tissue-inhibitory growth, and the second and third microporous membranes (242, 243) have an extended state maintained adjacent to the bonded peripheral edge of the first and second layers (114, 116).
[0178] Penetrations in the microstructure may allow fluid to penetrate into the microporous material. Such penetrations may vary in size, for example, based on the function of a given microporous membrane. In embodiments, either or both of the first and fourth microporous membranes (241, 244) may include penetrations of a size (or average size) range that allow for the internal growth of blood vessels and other tissues. In additional embodiments, either or both of the second and third microporous membranes (242, 243) are configured or selected such that the penetrations therein are of a size that minimizes, resists, or prevents the internal growth and adhesion of tissues while maintaining overall aqueous humor permeability.
[0179] The inner portion of the microporous material may have varying porosity, as can be seen in FIG. 3c. The inner portion may extend between the inner surface (251) of the wall and the outer surface (253) of the wall. In any of these portions of the wall, the porosity may range from relatively low porosity (LP), medium-low porosity (MLP), medium porosity (MP), medium-high porosity (MHP), and high porosity (HP). For the purposes of discussion here, assuming that the drain passes through the microporous material along a relatively straight path so as to sequentially contact the porosity of the inner surface (251) of the wall portion, the uniform inner portion, and the outer surface (253) of the wall portion, the composite flow resistance may be represented by similarly connecting the porosity of each of the aforementioned portions. For example, the inner surface (251) of the wall portion typically has low porosity throughout [e.g., to resist tissue growth into the reservoir (130)], and the inner portion and the outer surface (253) of the wall portion may have any of the porosities mentioned above. In this situation, if the inner portion has medium porosity, for example, the inner portions have medium porosity and the outer surface (253) of the wall portion has high porosity, the flow path through the microporous material from the reservoir (130) to the tissue surrounding the device may be represented as LP-MP-HP. More embodiments are discussed below.
[0180] Various flow paths may exist within the microporous material. A relatively linear flow path may include the region LP1-LP4-LP5, for example, or LP3-MHP1-MP1-MLP1. Under some conditions, for example, under conditions where high pressure exists in the reservoir (130), at least some of the flow may proceed through the most direct path through the microporous material, such as LP1-LP4-LP5 or LP2-HP1-HP2. While some flow paths may be relatively linear, non-linear flow paths also exist. For example, under certain conditions, at least some of the flow may proceed to flow through regions of progressively lower resistance, such as LP1-HP1-HP2 or LP3-MHP1-HP1-HP2. As is understood, the microstructure of the microporous material may undergo a modification process to obtain a specific type of flow through the microstructure. For example, the microstructure may have relatively uniform layers throughout the microstructure, or, as illustrated herein, may have variable portions throughout the thickness of the microporous material.
[0181] In the embodiments, the wall portion forms a wall portion thickness extending between the inner surface (251) of the wall portion and the outer surface (253) of the wall portion. The wall portion thickness may form an inner region of the wall portion having a transitional porosity between the porosity of the low-porous surface of the inner surface (251) of the wall portion and the porosity of the high-porous surface of the outer surface (253) of the wall portion. Additionally or alternatively, the inner region may have an inner region porosity equal to the porosity of the low-porous surfaces of the inner and outer surfaces. Additionally or alternatively, the inner region may have an inner region porosity equal to the porosity of the low-porous surface of the inner surface. Additionally or alternatively, the inner region may have an inner region porosity equal to the porosity of the high-porous surface of the outer surface.
[0182] FIG. 4a illustrates a flowchart of a method (400) according to embodiments of the present disclosure. As illustrated, the method (400) may be useful for forming a glaucoma drainage device disclosed herein and may include a drainage system including a drainage system (100) disclosed elsewhere in the present invention. In step 401, the method (400) may include the step of placing a first portion of a first microporous material over a second portion of a second microporous material. Each of the first microporous material and the second microporous material is transitioning from a hydrophobic state to a hydrophilic state. In step 403, the method (400) may include the step of fixing the first portion and the second portion to form a wall having a reservoir between them. The reservoir may be configured to be in fluid communication with the inside of the eye to receive drainage flowing from a portion inside the eye toward the reservoir. As the wall transitions from a hydrophobic state to a hydrophilic state, it may form a variable flow resistance. In the embodiments, at step 405, the method (400) may include the step of securing a suction conduit between the first part and the second part. The suction conduit may be configured to receive drainage.
[0183] When configuring the discharge system, particularly when it involves joining parts of the discharge system, the user may pay attention. In the embodiments, fixing the first part to the second part may include preventing the first microporous membrane from being joined to the fourth microporous membrane. In the embodiments, fixing the first part to the second part may include arranging the first layer and the second layer in a stacked configuration such that the first microporous membrane and the fourth microporous membrane are the outermost membranes of the wall and the second microporous membrane and the third microporous membrane are the innermost membranes of the wall.
[0184] Another method (450) is illustrated in FIG. 4b. This method is a method of use for a discharge device, including a discharge device (110), disclosed elsewhere in the present invention. In step 451, the method (450) may include the step of guiding drainage from a part inside a person to flow toward a reservoir in the discharge device. In step 453, the method (450) may include the step of collecting drainage in a reservoir until the microporous material transitions from a hydrophobic state to a partially hydrophilic state. In step 455, the method (450) may include the step of guiding drainage from the reservoir to flow through a conforming wall to a part of the body outside the eye.
[0185] The system illustrated in FIGS. 1a–1c is provided as an example of various features of the system described above, and while combinations of these exemplified features are clearly within the scope of the invention, such examples and examples are not intended to suggest that the concept of the invention provided herein is limited to a smaller number of features, additional features, or alternative features for one or more of the features illustrated in FIGS. 1a–1c. For example, in various embodiments, the components and / or characteristics of the system illustrated in FIGS. 1a–1c may include components and / or characteristics described with respect to any other drawings, such as FIGS. 2a–2e, FIGS. 3a–3c, FIGS. 4a and FIGS. 4b, etc. It should also be understood that the opposite holds true. One or more of the components illustrated in FIGS. 1a–1c may be used in addition to or as alternatives to the components illustrated in FIGS. 2a–2e, FIGS. 3a–3c, FIGS. 4a and FIGS. 4b. This corresponds to any drawing and the components and characteristics illustrated in this drawing and discussed herein in relation thereto.
[0186] FIGS. 7a and 7b illustrate an example of a method for testing whether a surface is hydrophobic or hydrophilic, also known as the Cecil drop method. This test is typically performed using an optical tensiometer, ranging from manual devices to fully automated systems. In both examples, a drop of liquid or fluid ("liquid") is placed on the surface to be tested, in this case, the surface being the wall (112) of the glaucoma drainage device (110) (indicated by the horizontal arrow). Subsequently, the static contact angle (θ) of the liquid from the surface, i.e., the wall (112), is measured by capturing an image of the drop using a high-resolution camera, and the contact angle can be automatically determined from the camera using any suitable software. In FIG. 7a, the contact angle is obtuse, i.e., greater than 90 degrees, which indicates that the surface of the wall (112) is hydrophobic. In FIG. 7b, the contact angle is acute, i.e., less than 90 degrees, which indicates that the surface of the wall (112) is hydrophilic. In some embodiments, the transition from a hydrophobic state to a hydrophilic state results in a reduction of the contact angle by at least 10 degrees, at least 15 degrees, at least 20 degrees, at least 25 degrees, at least 30 degrees, at least 35 degrees, at least 40 degrees, at least 45 degrees, at least 50 degrees, at least 55 degrees, at least 60 degrees, at least 65 degrees, at least 70 degrees, at least 75 degrees, at least 80 degrees, at least 85 degrees, at least 90 degrees, or any other suitable value or range between these values. As previously described, the wall (112) or, more specifically, the microporous material of the wall can transition from a hydrophobic state to a hydrophilic state, and the rate or rate of such transition can be measured using this method.
[0187] FIGS. 8a through 8e show different stages of the wall (112) as the wall (112) transitions from one state to another, as shown in five different backlight microscope images. Measurements can be taken using a process determined by the following steps: (1) a device (110) having a reservoir (130) is connected in series with any suitable micropump device having a pressure sensor in a flow relationship; (2) the pump flow rate is arbitrarily set to 50 μL / min and the micropump device is operated to apply a predetermined pressure by injecting fluid (liquid) into the reservoir (130); (3) the pressure measured for the reservoir (130) can be recorded over time; and (4) changes in the measured pressure are appropriately detected / recorded over periods such as 3 days, 7 days, 14 days, 30 days, etc. After that, as done to produce FIGS. 8a to 8e in one embodiment, the device (110) can be placed on a backlight stage for observation.
[0188] FIG. 8a is an image taken on day 0, FIG. 8b is an image taken on day 3, FIG. 8c is an image taken on day 7, FIG. 8d is an image taken on day 14, and FIG. 8e is an image taken on day 30 after the reservoir (130) has been filled with fluid. In FIG. 8a, the outline of the reservoir (130) is shown as a white dashed line for reference. The wall (112) is shown to include a relatively darker area (800) and a relatively brighter area (802). The brighter area (802) represents an area of the wall (112) that is more translucent than the darker area (800), translucency indicates the amount of wettability, transparency, and / or hydrophilicity of the wall (112) as it transitions from one state to another. Accordingly, in the hydrophobic state, the microporous material is opaque or less translucent, and in the hydrophilic state, the microporous material is transparent or more translucent. Hereinafter, the term “opaque” may be used when an object has, for example, less than 20% optical transmittance, less than 15% optical transmittance, less than 10% optical transmittance, or less than 5% optical transmittance. The term “translucent” may be used when an object has an optical transmittance greater than “opaque” and less than “translucent,” such as, for example, 20% to 80% optical transmittance. The term “translucent” may be used when an object has, for example, more than 80% transmittance, more than 85% transmittance, more than 90% transmittance, or more than 95% transmittance. In some embodiments, the microporous material may be transparent when it is possible to observe the object through the material.
[0189] As illustrated in FIG. 8a, on day 0, substantially the entire surface of the wall (112) is shown as a darker area (800) that is opaque. As illustrated in FIG. 8b, on day 3, a translucent area [brighter area (802)] appears in some section of the wall (112). As illustrated in FIG. 8c, on day 7, the translucent area [brighter area (802)] spreads over a wider section of the wall (112) than in FIG. 8b, and this spread continues into day 14 as illustrated in FIG. 8d. As illustrated in FIG. 8e, on day 30, substantially the entire surface of the wall (112) shows a brighter area (802) that is transparent. Accordingly, over 30 days, the wall (112) transitions from an opaque hydrophobic state to a translucent hydrophilic state.
[0190] FIGS. 9a through 9c show different stages of the wall (112) as it transitions from one state to another, as shown in three different microscope images. In these figures, the white area is the unwet area (900) corresponding to the darker area (800) in FIGS. 8a through 8e, and the shaded area is the wet area (902) corresponding to the brighter area (802) in FIGS. 8a through 8e. The wall (112) of the device (110) as depicted is shown in a constant ratio as indicated by a ruler representing centimeters (in FIG. 9a) and millimeters (in FIG. 9c). Accordingly, in FIG. 9a, an image taken on day 3, most of the surface of the wall (112) is not wet and thus shows hydrophobic characteristics with the wet regions (902) distributed throughout, whereas in FIG. 9b, an image taken on day 7, a portion of the wall (112) is wet inside the body, and in FIG. 9c, an image taken on day 30 [where the dotted line shows the periphery of the wall (112)], substantially the entire surface of the wall (112) is wet and thus shows hydrophilic characteristics. Thus, over 30 days, the entire microporous material of the wall (112) transitions from a hydrophobic state to a hydrophilic state. In some embodiments, a first portion of the microporous material transitions from a hydrophobic state to a hydrophilic state within 3 days. In some embodiments, a second portion of the microporous material, different from the first portion, transitions from a hydrophobic state to a hydrophilic state within 7 days. The first and second parts may be the brighter area (802) shown in FIG. 8b or the shaded area (902) shown in FIG. 9a, which respectively show the wall (112) after 3 days of containing fluid in the reservoir (130) or after 3 days of wetting.Alternatively, the first and second parts may be the brighter area (802) shown in FIG. 8c or the shaded area (902) shown in FIG. 9b, which respectively show the wall (112) after 7 days of containing fluid in the reservoir (130) or after 7 days of wetting. In some embodiments, less than 10%, less than 7%, less than 5%, less than 3%, less than 1%, or any other suitable value or range between these values may be the first part that transitioned from a hydrophobic state to a hydrophilic state within 3 days. Also, in some embodiments, 10% to 20%, 7% to 15%, 5% to 10%, 3% to 5%, or any other suitable value or range between these values may be the sum of the first and second parts that transitioned from a hydrophobic state to a hydrophilic state within 7 days.
[0191] FIG. 10 is a graph (1000) with flow rate on the x-axis and pressure on the y-axis, illustrating a graph showing differences in the characteristics of the device (110) over time using three different lines when the device (110) undergoes wetting within the body. A solid line (1002) (represented by a rectangle) shows the initial state of the device (110) at the beginning of wetting, that is, when the device (110) is placed in an environment containing fluid / liquid to facilitate wetting. The initial state may be day 0 of being placed in a fluid / liquid environment. A dotted line (1004) (represented by a circle) shows the state of partial wetting, which may be between day 0 and day 30, for example, day 3, day 7, day 14, or any other suitable number of days between day 0 and day 30, excluding day 0 and day 30. Another dashed line (1006) (represented by a triangle) shows a state of total or complete wetting, which may be day 30. Graph (1000) compares the slopes of lines (1002, 1004, and 1006) representing flow resistance. It should be understood that flow resistance is calculated as follows: flow resistance = pressure / flow rate. Therefore, since the slope decreases from line (1002) to line (1006), flow resistance also decreases from the initial state of wetting (day 0) to the final state of wetting (day 30).
[0192] FIG. 11a illustrates a graph (1100) with time after transplantation on the x-axis and the rate of change in the flow resistance of the device (110) on the y-axis. The flow resistance is shown to decrease over time from 100% on day 3 to 0% on day 30. Although the change in flow resistance over time is shown as asymptotic, in some embodiments, the change in flow resistance over time may be more linear. In some embodiments, a portion of the flow resistance does not change, which is expressed as the "potential flow resistance" of the device. This portion of the unchanging flow resistance is the flow resistance of the portion of the structure affected by wetting of the device as the device transitions from a hydrophobic state to a hydrophilic state, at which point the device has only potential flow resistance. For example, in the illustrated embodiment, 0% flow resistance indicates that the flow resistance of the device, which can change, has reached 0%, whereas the potential flow resistance of the device remains due to the fact that no physical device can effectively lose all flow resistance unless the device is decomposed or melted. Since the device (110) does not decompose over time but is wetted and transitions to its hydrophilic state as described above, the device will retain potential flow resistance even after the wetting is complete, for example, after the 30-day mark.
[0193] FIG. 11b illustrates a graph (1102) with time after implantation on the x-axis and a percentage of the area of the device (110) that has been completely wetted on the y-axis. The graph (1102) shows an increase in the percentage of the area of the wetted device as time elapses from day 0 (the start of wetting) to day 30, which is the point at which 100% of the area of the device is completely wetted. In some embodiments, such as those illustrated in the graph, the rate of increase is substantially linear over time, but in some embodiments, the change may be non-linear. In some embodiments, the "substantially linear" rate of increase may be determined as a set of percentage data points having a coefficient of determination (also called R2 value) of at least 0.90, at least 0.91, at least 0.92, at least 0.93, at least 0.94, at least 0.95, or any other appropriate value or range between these values, for example, not greater than 1.
[0194] The invention of this application has been described above comprehensively and with respect to specific embodiments. It will be apparent to those skilled in the art that various modifications and variations may be made to the embodiments without departing from the scope of this disclosure. Accordingly, the embodiments are intended to encompass modifications and variations of the invention as long as they fall within the scope of the appended claims and their equivalents.
Claims
Claim 1 A glaucoma shunt for draining fluid from the eye to the tissues surrounding the eye, wherein the glaucoma shunt is implantable within the tissues of the eye, and the glaucoma shunt comprises: a shunt body formed of a microporous material arranged to form a reservoir within the shunt body; and a conduit communicating with the reservoir and fluid, wherein the conduit is implantable in the eye to allow fluid at the distal end of the conduit to flow through the conduit and accumulate in the reservoir, and as the fluid accumulated in the reservoir is dispersed through the microporous material to the tissues surrounding the eye, the microporous material transitions from a hydrophobic state to a hydrophilic state within 30 days, thereby providing variable flow resistance as the microporous material transitions from a hydrophobic state to a hydrophilic state. Claim 2 A glaucoma shunt according to claim 1, wherein a first portion of the microporous material transitions from a hydrophobic state to a hydrophilic state within 3 days. Claim 3 A glaucoma shunt according to paragraph 2, wherein a second part of a microporous material different from the first part transitions from a hydrophobic state to a hydrophilic state within 7 days. Claim 4 A glaucoma shunt according to any one of claims 1 to 3, wherein the entire microporous material transitions from a hydrophobic state to a hydrophilic state within 30 days. Claim 5 A glaucoma shunt according to any one of paragraphs 1 to 3, wherein, in a hydrophobic state, the microporous material is opaque. Claim 6 A glaucoma shunt according to any one of paragraphs 1 to 3, wherein the microporous material is transparent in a hydrophilic state. Claim 7 A glaucoma shunt according to any one of paragraphs 1 to 3, wherein the shunt body has a maximum thickness of 500 μm or less. Claim 8 A glaucoma shunt according to any one of claims 1 to 3, wherein in a hydrophobic state, a water droplet placed on the surface of a microporous material forms a contact angle greater than 90 degrees with respect to the surface, and in a hydrophilic state, a water droplet placed on the surface of a microporous material forms a contact angle less than 90 degrees with respect to the surface, and the transition from a hydrophobic state to a hydrophilic state results in a reduction of the contact angle by at least 10 degrees. Claim 9 A glaucoma shunt according to any one of claims 1 to 3, wherein the variable flow resistance is greater in the hydrophobic state than in the hydrophilic state. Claim 10 A glaucoma shunt according to any one of claims 1 to 3, wherein the microporous material is more translucent in a hydrophilic state than in a hydrophobic state. Claim 11 A glaucoma shunt according to any one of claims 1 to 3, wherein the shunt body has a continuous wall forming a reservoir, the reservoir opening of said continuous wall communicates with an internal reservoir, and the conduit is received in an interlocking manner through said opening; at least a portion of said continuous wall has a wall portion composed of a microporous material, said wall portion has an inner surface facing the internal reservoir and an outer surface opposite to facing the external region of the human eye, said inner surface of said wall portion has a low-porous surface extending over the entire inner surface of said wall portion, and said outer surface of said wall portion has alternating low-porous and high-porous surfaces. Claim 12 A glaucoma shunt according to any one of claims 1 to 3, wherein the microporous material comprises a first layer having a first microporous membrane integrated with a second microporous membrane and a second layer having a third microporous membrane integrated with a fourth microporous membrane. Claim 13 In paragraph 12, the microporous material comprises expanded polytetrafluoroethylene (ePTFE) in a glaucoma shunt. Claim 14 A glaucoma shunt according to claim 13, wherein the aqueous humor permeability of the first microporous membrane is greater than the aqueous humor permeability of the second microporous membrane; and the aqueous humor permeability of the fourth microporous membrane is greater than the aqueous humor permeability of the third microporous membrane. Claim 15 A glaucoma shunt according to claim 14, wherein the first layer and the second layer are laminated such that the first microporous membrane and the fourth microporous membrane are the outermost membranes of the shunt body and the second microporous membrane and the third microporous membrane are the innermost membranes of the shunt body forming a reservoir. Claim 16 In paragraph 12, the first microporous membrane has the first microporous membrane water permeability, the second microporous membrane has the second microporous membrane water permeability, the third microporous membrane has the third microporous membrane water permeability, and the fourth microporous membrane has the fourth microporous membrane water permeability, the second microporous membrane water permeability is identical to the third microporous membrane water permeability, the first microporous membrane water permeability is identical to the fourth microporous membrane water permeability, and each of the second microporous membrane water permeability and the third microporous membrane water permeability is the first microporous membrane water permeability and the fourth Glaucoma shunt that is different from a microporous membrane aqueous humor permeability. Claim 17 A glaucoma shunt according to claim 12, wherein the second and third microporous membranes are bonded together along the peripheral edges of the first and second layers to form a reservoir and the reservoir is placed between the second and third microporous membranes, the second and third microporous membranes are configured to have a porosity that resists tissue endogly growth, the first and fourth microporous membranes are configured to have a porosity that allows tissue endogly growth, and the second and third microporous membranes have an extended state maintained adjacent to the peripheral edges of the first and second layers. Claim 18 In paragraph 12, the reservoir is configured to move between a contracted state in which the second and third microporous membranes resist fluid flow between them, and an expanded state in which fluid is allowed to flow between the second and third microporous membranes. Claim 19 In paragraph 18, a glaucoma shunt in which fluid flow into the reservoir is directed from the distal end of the conduit toward the periphery of the chamber. Claim 20 A glaucoma shunt according to paragraph 18, wherein the reservoir has a proximal section of the reservoir adjacent to the distal end of the conduit and a distal section of the reservoir positioned opposite the proximal section of the reservoir, and during fluid drainage, the proximal section of the reservoir is configured to expand ahead of the distal section of the reservoir. Claim 21 A glaucoma shunt according to any one of claims 1 to 3, wherein the variable flow resistance corresponds to the rate of change of pressure with respect to flow rate over time. Claim 22 A glaucoma shunt according to claim 21, wherein the microporous material transitions from a hydrophobic state having a first flow resistance to a partially hydrophilic state having a second flow resistance, and subsequently to a hydrophilic state having a third flow resistance, wherein the first flow resistance is greater than both the second flow resistance and the third flow resistance, and the second flow resistance is greater than the third flow resistance. Claim 23 A glaucoma shunt according to any one of claims 1 to 3, wherein the microporous material is configured to transition from a hydrophobic state to a hydrophilic state based on wetting of the microporous material by a fluid, and the microporous material is configured such that wetting of the outer part of the shunt body occurs prior to wetting of the reservoir. Claim 24 A water-repellent dispersion device comprising: a device body formed of a microporous material disposed to form a reservoir within the device body, wherein the reservoir is configured to receive and accumulate fluid, and as the fluid accumulated in the reservoir is dispersed through the microporous material into a tissue surrounding the device, the microporous material transitions from a hydrophobic state to a hydrophilic state within 30 days, thereby providing variable flow resistance as the microporous material transitions from a hydrophobic state to a hydrophilic state. Claim 25 A water-repellent dispersion device according to claim 24, wherein a first portion of the microporous material transitions from a hydrophobic state to a hydrophilic state within 3 days. Claim 26 An aqueous dispersion device according to claim 25, wherein a second part of a microporous material different from the first part transitions from a hydrophobic state to a hydrophilic state within 7 days. Claim 27 An aqueous dispersion device according to any one of claims 24 to 26, wherein the entire microporous material transitions from a hydrophobic state to a hydrophilic state within 30 days. Claim 28 A water-repellent dispersion device according to any one of claims 24 to 26, wherein, in a hydrophobic state, the microporous material is opaque. Claim 29 A water-repellent dispersion device according to any one of claims 24 to 26, wherein the microporous material is transparent in a hydrophilic state. Claim 30 A water-repellent dispersion device according to any one of claims 24 to 26, wherein the device body has a maximum thickness of 500 μm or less. Claim 31 An aqueous dispersion device according to any one of claims 24 to 26, wherein in a hydrophobic state, a water droplet placed on the surface of a microporous material forms a contact angle greater than 90 degrees with respect to the surface, and in a hydrophilic state, a water droplet placed on the surface of a microporous material forms a contact angle less than 90 degrees with respect to the surface, and the transition from a hydrophobic state to a hydrophilic state results in a reduction of the contact angle by at least 10 degrees. Claim 32 A water-dispersing device according to any one of claims 24 to 26, wherein the variable flow resistance is greater in the hydrophobic state than in the hydrophilic state. Claim 33 An aqueous dispersion device according to any one of claims 24 to 26, wherein the microporous material is more translucent in a hydrophilic state than in a hydrophobic state. Claim 34 An aqueous dispersion device according to any one of claims 24 to 26, wherein the microporous material comprises a first layer having a first microporous membrane bonded to a second microporous membrane and a second layer having a third microporous membrane bonded to a fourth microporous membrane. Claim 35 A waterproof dispersion device according to claim 34, wherein the microporous material comprises expanded polytetrafluoroethylene (ePTFE). Claim 36 A water-repellent dispersion device according to claim 35, wherein the water-repellent permeability of the first microporous membrane is greater than the water-repellent permeability of the second microporous membrane, and the water-repellent permeability of the fourth microporous membrane is greater than the water-repellent permeability of the third microporous membrane. Claim 37 A water-dispersing device according to claim 36, wherein the first layer and the second layer are configured in a stacked manner such that the first microporous membrane and the fourth microporous membrane are the outermost membranes of the device body and the second microporous membrane and the third microporous membrane are the innermost membranes of the device body forming a reservoir. Claim 38 In paragraph 34, the first microporous membrane has the first microporous membrane water permeability, the second microporous membrane has the second microporous membrane water permeability, the third microporous membrane has the third microporous membrane water permeability, and the fourth microporous membrane has the fourth microporous membrane water permeability, the second microporous membrane water permeability is identical to the third microporous membrane water permeability, the first microporous membrane water permeability is identical to the fourth microporous membrane water permeability, and each of the second microporous membrane water permeability and the third microporous membrane water permeability is the first microporous membrane water permeability and the fourth A water-dispersing device that is different from a microporous membrane water-permeability device. Claim 39 An aqueous dispersion device according to claim 34, wherein the second and third microporous membranes are bonded together along the peripheral edges of the first and second layers to form a reservoir and the reservoir is disposed between the second and third microporous membranes, the second and third microporous membranes are configured to have a porosity that resists tissue-inhibitory growth, the first and fourth microporous membranes are configured to have a porosity that allows tissue-inhibitory growth, and the second and third microporous membranes have an extended state maintained adjacent to the peripheral edges of the first and second layers. Claim 40 In paragraph 34, the reservoir is configured to move between a contracted state in which the second and third microporous membranes resist fluid flow between them, and an expanded state in which fluid is allowed to flow between the second and third microporous membranes. Claim 41 A water dispersion device according to claim 40, wherein the fluid flow into the storage is directed from the proximal part of the storage toward the periphery of the chamber. Claim 42 A water dispersing device according to claim 40, wherein the reservoir has a reservoir proximal section configured to be positioned adjacent to a reservoir port through which the receiving fluid passes, and a reservoir distal section configured to be positioned opposite the reservoir proximal section, and during the discharge of the fluid, the reservoir proximal section is configured to expand ahead of the reservoir distal section. Claim 43 A water dispersion device according to any one of claims 24 to 26, wherein the variable flow resistance corresponds to the rate of change of pressure with respect to the flow rate over time. Claim 44 In paragraph 43, the microporous material transitions from a hydrophobic state having a first flow resistance to a partially hydrophilic state having a second flow resistance, and then to a hydrophilic state having a third flow resistance; the first flow resistance is greater than both the second flow resistance and the third flow resistance, and the second flow resistance is greater than the third flow resistance, in a hydrophobic dispersion device. Claim 45 An antiwater dispersion device according to any one of claims 24 to 26, wherein the microporous material is configured to transition from a hydrophobic state to a hydrophilic state based on wetting of the microporous material by a fluid, and the microporous material is configured such that wetting of the outer part of the device body occurs prior to wetting of the reservoir. Claim 46 A method for forming an implantable glaucoma drainage device comprising: a step of arranging a microporous material to form a device body formed therein, wherein the device body is configured to receive and accumulate fluid; and a step of fixing a portion of the microporous material forming the reservoir so as the microporous material transitions from a hydrophobic state to a hydrophilic state within 30 days as the fluid accumulates in the reservoir, thereby providing variable flow resistance as the microporous material transitions from a hydrophobic state to a hydrophilic state as the fluid is dispersed through the microporous material into tissues surrounding the device. Claim 47 A method according to paragraph 46 in which a first portion of the microporous material transitions from a hydrophobic state to a hydrophilic state within 3 days. Claim 48 A method according to claim 47 in which a second part of a microporous material, different from the first part, transitions from a hydrophobic state to a hydrophilic state within 7 days. Claim 49 A method according to any one of claims 46 to 48, wherein the entire microporous material transitions from a hydrophobic state to a hydrophilic state within 30 days. Claim 50 A method according to any one of paragraphs 46 to 48, wherein the microporous material is opaque in a hydrophobic state. Claim 51 A method in which, in any one of paragraphs 46 to 48, the microporous material is transparent in a hydrophilic state. Claim 52 A method according to any one of claims 46 to 48, wherein the device body has a maximum thickness of 500 μm or less. Claim 53 A method according to any one of claims 46 to 48, wherein in a hydrophobic state, a water droplet placed on the surface of a microporous material forms a contact angle greater than 90 degrees with respect to the surface, and in a hydrophilic state, a water droplet placed on the surface of a microporous material forms a contact angle less than 90 degrees with respect to the surface, and the transition from a hydrophobic state to a hydrophilic state results in a reduction of the contact angle by at least 10 degrees. Claim 54 A method according to any one of claims 46 to 48, wherein the variable flow resistance is greater in the hydrophobic state than in the hydrophilic state. Claim 55 A method according to any one of claims 46 to 48, wherein the microporous material is more translucent in a hydrophilic state than in a hydrophobic state. Claim 56 A method according to any one of claims 46 to 48, further comprising the step of a reservoir receiving fluid through a port of a device body and securing a suction conduit configured to receive drainage to the device body at the port. Claim 57 A method according to any one of claims 46 to 48, wherein one or more microporous materials comprise a first layer having a first microporous membrane bonded to a second microporous membrane and a second layer having a third microporous membrane bonded to a fourth microporous membrane, and fixing a portion of one or more microporous materials comprises bonding the second microporous membrane to the third microporous membrane. Claim 58 A method according to claim 57, wherein the second and third microporous membranes are bonded together along the peripheral edges of the first and second layers to form a reservoir and the reservoir is placed between the second and third microporous membranes, the second and third microporous membranes are configured to have a porosity that resists tissue-inhibitory growth, the first and fourth microporous membranes are configured to have a porosity that allows tissue-inhibitory growth, and the second and third microporous membranes have an extended state maintained adjacent to the peripheral edges of the first and second layers. Claim 59 A method according to claim 57, wherein fixing a portion of the microporous material includes preventing the first microporous membrane from being bonded to the fourth microporous membrane. Claim 60 A method according to claim 57, wherein fixing a portion of the microporous material comprises arranging the first layer and the second layer in a stacked configuration such that the first microporous membrane and the fourth microporous membrane are the outermost membranes of the device body and the second microporous membrane and the third microporous membrane are the innermost membranes of the device body. Claim 61 A glaucoma drainage device for draining fluid from an internal region of a human eye to an external region of a human eye: a body having a continuous wall forming an internal reservoir within the body and a reservoir opening in the wall communicating with the internal reservoir; A conduit extending from a body by a conduit length, having a first end and a second end opposite each other, forming a passage through the conduit extending between the first end and the second end opposite each other, wherein the first end of the conduit engages with a reservoir opening to provide a fluid connection between the second end of the conduit and a reservoir, and the conduit length is sufficient to position the first end of the conduit in an external region of the human eye and the second end of the conduit in an internal region of the human eye, wherein at least a portion of the continuous wall has a wall portion composed of a microporous material, wherein the wall portion has an inner surface facing the internal reservoir and an outer surface opposite to facing the external region of the human eye, wherein the inner surface of the wall portion has a low-porous surface extending over the entire inner surface of the wall portion, and the outer surface of the wall portion has alternating low-porous and high-porous surfaces, wherein the wall portion has an initial hydrophobic state, and when a fluid comes into contact with the wall portion, the initial hydrophobic state transitions to a final hydrophilic state within 30 days. Glaucoma drainage device. Claim 62 A glaucoma drainage device according to claim 61, wherein a first portion of the microporous material transitions from a hydrophobic state to a hydrophilic state within 3 days. Claim 63 A glaucoma drainage device according to claim 62, wherein a second part of a microporous material different from the first part transitions from a hydrophobic state to a hydrophilic state within 7 days. Claim 64 A glaucoma drainage device according to any one of claims 61 to 63, wherein the entire microporous material transitions from a hydrophobic state to a hydrophilic state within 30 days. Claim 65 A glaucoma drainage device according to any one of claims 61 to 63, wherein, in a hydrophobic state, the microporous material is opaque. Claim 66 A glaucoma drainage device according to any one of claims 61 to 63, wherein the microporous material is transparent in a hydrophilic state. Claim 67 A glaucoma drainage device according to any one of claims 61 to 63, wherein the device body has a maximum thickness of 500 μm or less. Claim 68 A glaucoma drainage device according to any one of claims 61 to 63, wherein in a hydrophobic state, a water droplet placed on the surface of a microporous material forms a contact angle greater than 90 degrees with respect to the surface, and in a hydrophilic state, a water droplet placed on the surface of a microporous material forms a contact angle less than 90 degrees with respect to the surface, and the transition from a hydrophobic state to a hydrophilic state results in a reduction of the contact angle by at least 10 degrees. Claim 69 A glaucoma drainage device according to any one of claims 61 to 63, wherein the variable flow resistance is greater in the hydrophobic state than in the hydrophilic state. Claim 70 A glaucoma drainage device according to any one of claims 61 to 63, wherein the microporous material is more translucent in a hydrophilic state than in a hydrophobic state. Claim 71 A glaucoma drainage device according to any one of claims 61 to 63, wherein the wall portion forms a wall portion thickness extending between the inner surface and the outer surface, and the wall portion thickness forms an internal region of the wall portion having transition porosity between the porosity of the low-porous surface of the inner surface and the porosity of the high-porous surface of the outer surface. Claim 72 A glaucoma drainage device according to any one of claims 61 to 63, wherein the wall portion forms a wall portion thickness extending between an inner surface and an outer surface, the wall portion thickness forms an internal region of the wall portion extending between a low-porous surface of the inner surface and a low-porous surface of the outer surface, and the internal region has an internal region porosity identical to the porosity of the low-porous surfaces of the inner surface and the outer surface. Claim 73 A glaucoma drainage device according to any one of claims 61 to 63, wherein the wall portion forms a wall portion thickness extending between an inner surface and an outer surface, the wall portion thickness forms an internal region of the wall portion extending between a low-porous surface of the inner surface and a high-porous surface of the outer surface, and the internal region has an internal region porosity identical to the porosity of the low-porous surface of the inner surface. Claim 74 A glaucoma drainage device according to any one of claims 61 to 63, wherein the wall portion forms a wall portion thickness extending between an inner surface and an outer surface, the wall portion thickness forms an internal region of the wall portion extending between a low-porous surface of the inner surface and a high-porous surface of the outer surface, and the internal region has an internal region porosity identical to the porosity of the high-porous surface of the outer surface. Claim 75 A glaucoma drainage device according to any one of claims 61 to 63, wherein the fluid connection between the second end of the conduit and the reservoir is additionally extended from the reservoir through a microporous material to provide fluid communication from the reservoir to an external region of the human eye. Claim 76 In paragraph 75, a glaucoma drainage device in which the fluid communication forms a flow path through a microporous material. Claim 77 A glaucoma drainage device according to claim 76, wherein the flow path through the microporous material is in a direction away from the reservoir. Claim 78 A glaucoma drainage device according to claim 76, wherein the flow path through the microporous material proceeds from a microporous region having low porosity to a microporous region having high porosity. Claim 79 delete Claim 80 delete Claim 81 delete Claim 82 delete Claim 83 delete Claim 84 delete Claim 85 delete Claim 86 delete Claim 87 delete Claim 88 delete Claim 89 delete Claim 90 delete Claim 91 delete Claim 92 delete Claim 93 delete Claim 94 delete Claim 95 delete Claim 96 delete Claim 97 delete Claim 98 delete Claim 99 delete Claim 100 delete Claim 101 delete Claim 102 delete Claim 103 delete Claim 104 delete Claim 105 delete Claim 106 delete Claim 107 delete Claim 108 delete Claim 109 delete Claim 110 delete Claim 111 delete Claim 112 delete Claim 113 delete Claim 114 delete Claim 115 delete Claim 116 delete Claim 117 delete Claim 118 delete Claim 119 delete Claim 120 delete Claim 121 delete Claim 122 delete Claim 123 delete Claim 124 delete Claim 125 delete Claim 126 delete Claim 127 delete Claim 128 delete Claim 129 delete Claim 130 delete
Citation Information
Patent Citations
Integrated aqueous shunt for the treatment of glaucoma
JP2020509888A
Drug delivery devices
US20080147021A1
Remote actuated valve implant
US20100241241A1
MEMS device and method for delivery of therapeutic agents
US20160000602A1
